,pdb_id,chain_id,location,gene,amino_acid_original,list_amino_acid_variants,description,antigen_name,antigen_chain,antigen_species,resolution
0,4JPV,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120,hiv-1 clade a strain 93th057 gp120 with loop d and loopd v5replaced from hiv strain 3415v1 ,G,human immunodeficiency virus 1,2.827
1,4JPV,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120,hiv-1 clade a strain 93th057 gp120 with loop d and loopd v5replaced from hiv strain 3415v1 ,G,human immunodeficiency virus 1,2.827
2,7S3I,N,33,IGHV3-48,K,['S' 'E'],Ex4-D-Ala bound to the glucagon-like peptide-1 receptor/g protein complex (conformer 2),guanine nucleotide-binding protein g(s) subunit alphaisoforms short  | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1  | guanine nucleotide-binding protein g(i)/g(s)/g(o) subunitgamma-2 ,A | B | G,homo sapiens | homo sapiens | homo sapiens,2.51
3,4OGX,L,50,IGKV1-5,K,['D' 'K'],Crystal structure of Fab DX-2930 in complex with human plasma kallikrein at 2.4 Angstrom resolution,plasma kallikrein,A,homo sapiens,2.4
4,4IDJ,H,54,IGHV1-69,L,['F' 'L'],S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus,3.36
5,4IDJ,H,56,IGHV1-69,T,['T' 'I'],S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus,3.36
6,4IDJ,H,73,IGHV1-69,K,['E' 'K'],S.Aureus a-hemolysin monomer in complex with Fab,alpha-hemolysin,A,staphylococcus aureus,3.36
7,6HHC,H,50,IGHV3-23,G,['A' 'V'],"Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI",coagulation factor xi,A,homo sapiens,2.7
8,6HHC,H,52,IGHV3-23,G,['S' 'Y'],"Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI",coagulation factor xi,A,homo sapiens,2.7
9,6HHC,H,52A,IGHV3-23,P,['G' 'S'],"Allosteric Inhibition as a new mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated form of Coagulation Factor XI",coagulation factor xi,A,homo sapiens,2.7
10,2B1A,L,50,IGLV1-47,R,['R' 'S'],Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG1033 peptide,ug1033 peptide of exterior membrane glycoprotein gp120,P,,2.348
11,1TJI,H,54,IGHV2-5,D,['N' 'D'],Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 17mer epitope,envelope glycoprotein gp41,P,,2.2
12,1TJH,H,54,IGHV2-5,D,['N' 'D'],Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 11mer epitope,envelope glycoprotein gp41,P,,2.1
13,1TJG,H,54,IGHV2-5,D,['N' 'D'],Crystal Structure of the broadly neutralizing anti-HIV-1 antibody 2F5 in complex with a gp41 7mer epitope,envelope glycoprotein gp41,P,,2.0
14,4TSB,H,54,IGHV3-66,G,['G' 'C'],Structure of a lysozyme antibody complex,lysozyme c,A,gallus gallus,1.95
15,7RXI,L,50,IGLV3-21,D,['Y' 'D'],Fab234 in complex with the C-terminal alpha-TSR domain of P. falciparum,circumsporozoite protein,A,plasmodium falciparum (isolate 3d7),2.15
16,6CMI,D,54,IGHV1-69,L,['F' 'L'],Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,B,hendra virus,2.72
17,6CMI,D,56,IGHV1-69,I,['T' 'I'],Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,B,hendra virus,2.72
18,6CMG,C,54,IGHV1-69,L,['F' 'L'],Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,A,hendra virus,2.7
19,6CMG,C,56,IGHV1-69,I,['T' 'I'],Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3,glycoprotein g,A,hendra virus,2.7
20,6OZ3,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.15
21,6OZ3,H,61,IGHV1-2,W,['Q' 'H'],Crystal structure of broadly neutralizing antibody N49P9.1 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.15
22,1H0D,B,50,IGHV3-23,T,['A' 'V'],Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens,2.0
23,1H0D,B,52,IGHV3-23,S,['S' 'Y'],Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens,2.0
24,1H0D,B,52A,IGHV3-23,S,['G' 'S'],Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens,2.0
25,1H0D,B,53,IGHV3-23,G,['S' 'G'],Crystal structure of Human Angiogenin in complex with Fab fragment of its monoclonal antibody mAb 26-2F,angiogenin,C,homo sapiens,2.0
26,7XNF,H,54,IGHV3-66,G,['G' 'C'],Structure of SARS-CoV-2 antibody P2C-1F11 with GX/P2V/2017 RBD,spike protein s1,A,pangolin coronavirus,2.79
27,6W52,H,54,IGHV1-69,F,['F' 'L'],Prefusion RSV F bound by neutralizing antibody RSB1,fusion glycoprotein f1 fused with fibritin trimerizationdomain  | fusion glycoprotein f0,B | A,"human respiratory syncytial virus a,escherichia phage t2  | human respiratory syncytial virus a (straina2) ",3.74
28,4TSA,H,54,IGHV3-66,G,['G' 'C'],Structure of a lysozyme FAb complex,lysozyme c,A,gallus gallus,2.27
29,4TSC,H,54,IGHV3-66,G,['G' 'C'],Structure of a lysozyme antibody complex,lysozyme c,A,gallus gallus,1.92
30,7E5O,H,50,IGHV4-34,E,['E' 'Y'],Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.8
31,7E5O,H,52,IGHV4-34,N,['N' 'Y' 'I'],Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.8
32,7E5O,H,59,IGHV4-34,Y,['Y' 'N'],Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.8
33,7E5O,L,30,IGKV1-17,G,['R' 'S'],Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.8
34,7E5O,L,32,IGKV1-17,Y,['D' 'Y'],Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.8
35,7WP2,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 ,3.52
36,7WP0,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 ,0
37,7WP1,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 ,3.77
38,5CD5,C,50,IGHV1-2,W,['R' 'W'],Crystal structure of an immature VRC01-class antibody DRVIA7 from a Chinese donor bound to clade A/E HIV-1 gp120 core,93th057 hiv-1 gp120 core,A,human immunodeficiency virus 1,3.3960000000000004
39,5CD5,C,61,IGHV1-2,R,['Q' 'H'],Crystal structure of an immature VRC01-class antibody DRVIA7 from a Chinese donor bound to clade A/E HIV-1 gp120 core,93th057 hiv-1 gp120 core,A,human immunodeficiency virus 1,3.3960000000000004
40,6OZ4,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain.,envelope glycoprotein gp160,G,human immunodeficiency virus 1,4.05
41,6OZ4,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 Env trimer ectodomain.,envelope glycoprotein gp160,G,human immunodeficiency virus 1,4.05
42,7TLZ,B,26,IGHV3-30,G,['G' 'A'],SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement,spike glycoprotein,J,homo sapiens,3.3
43,7TLZ,B,52,IGHV3-30,R,['S' 'R'],SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement,spike glycoprotein,J,homo sapiens,3.3
44,7SU1,H,33,IGHV3-30,T,['A' 'G'],Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4,cytotoxic t-lymphocyte protein 4,C,homo sapiens,2.53
45,7SU1,H,50,IGHV3-30,F,['V' 'F'],Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4,cytotoxic t-lymphocyte protein 4,C,homo sapiens,2.53
46,7SU1,H,52,IGHV3-30,S,['S' 'R'],Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4,cytotoxic t-lymphocyte protein 4,C,homo sapiens,2.53
47,3GO1,H,31,IGHV4-59,N,['S' 'Y'],Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,,1.89
48,3GO1,H,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,,1.89
49,3GO1,H,50,IGHV4-59,Y,['Y' 'R'],Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,,1.89
50,3GO1,H,58,IGHV4-59,N,['N' 'Y'],Crystal structure of anti-HIV-1 Fab 268-D in complex with V3 peptide MN,envelope glycoprotein gp160,P,,1.89
51,7KRA,I,25,IGHV4-34,Y,['Y' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
52,7KRA,I,26,IGHV4-34,G,['G' 'F'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
53,7KRA,I,27,IGHV4-34,G,['G' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
54,7KRA,I,28,IGHV4-34,S,['S' 'T' 'G'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
55,7KRA,I,29,IGHV4-34,F,['F' 'V' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
56,7KRA,I,30,IGHV4-34,S,['S' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
57,7KRA,I,31,IGHV4-34,G,['G' 'W'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
58,7KRA,I,32,IGHV4-34,Y,['Y' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
59,7KRA,I,52,IGHV4-34,N,['N' 'Y' 'I'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
60,7KRA,I,53,IGHV4-34,H,['H' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to Fab-DH4 in lipid nanodiscs,er membrane protein complex subunit 1,A,saccharomyces cerevisiae,3.2
61,7KET,A,52,IGHV3-23,S,['S' 'Y'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,2.0
62,7KET,A,52A,IGHV3-23,H,['G' 'S'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,2.0
63,7KET,A,53,IGHV3-23,S,['S' 'G'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,2.0
64,7KET,A,55,IGHV3-23,G,['G' 'S'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,2.0
65,7WRJ,A,54,IGHV2-5,D,['N' 'D'],Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-4637 Fab,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,0
66,7E3B,B,31,IGHV4-59,S,['S' 'Y'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
67,7E3B,B,32,IGHV4-59,Y,['Y' 'W' 'H'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
68,7E3B,B,33,IGHV4-59,Y,['Y' 'S'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
69,7E3B,B,50,IGHV4-59,Y,['Y' 'R'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
70,7E3B,B,53,IGHV4-59,Y,['Y' 'T'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
71,7E3B,B,58,IGHV4-59,N,['N' 'Y'],SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.2
72,7E39,C,31,IGHV3-33,S,['S' 'R'],SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
73,7E39,C,35,IGHV3-33,H,['H' 'Y'],SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
74,7E39,C,52,IGHV3-33,W,['W' 'S'],SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
75,8DLX,H,26,IGHV3-30,G,['G' 'A'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
76,8DLX,H,50,IGHV3-30,N,['V' 'F'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
77,8DLX,H,52,IGHV3-30,Y,['S' 'R'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
78,8DLX,H,60,IGHV3-30,N,['A' 'T'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
79,8DLX,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6,spike glycoprotein | spike glycoprotein,C | A,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
80,8DLY,H,50,IGHV3-30,N,['V' 'F'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
81,8DLY,H,52,IGHV3-30,Y,['S' 'R'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
82,8DLY,H,60,IGHV3-30,N,['A' 'T'],Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
83,8DLZ,H,50,IGHV3-30,N,['V' 'F'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
84,8DLZ,H,52,IGHV3-30,Y,['S' 'R'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
85,8DLZ,H,60,IGHV3-30,N,['A' 'T'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
86,8DLR,H,54,IGHV1-69,L,['F' 'L'],Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
87,1JPS,H,33,IGHV3-43,Y,['T' 'A'],Crystal structure of tissue factor in complex with humanized Fab D3h44,tissue factor,T,homo sapiens,1.85
88,7EKB,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1,1.45
89,7EKB,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1,1.45
90,7EKB,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1,1.45
91,7EKB,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of 4E10 modified with pyrene acetamide,mper region of the hiv-1 envelope glycoprotein proteingp41 ,P,human immunodeficiency virus 1,1.45
92,7EKK,H,33,IGHV1-69,A,['A' 'T'],Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1,1.7
93,7EKK,H,50,IGHV1-69,G,['G' 'R'],Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1,1.7
94,7EKK,H,54,IGHV1-69,L,['F' 'L'],Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1,1.7
95,7EKK,H,56,IGHV1-69,I,['T' 'I'],Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide,mper region of the envelope glycoprotein gp41 from hiv-1,P,human immunodeficiency virus 1,1.7
96,7BYR,L,50,IGKV1-5,K,['D' 'K'],BD23-Fab in complex with the S ectodomain trimer,sars-cov-2 spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.84
97,7N8I,H,33,IGHV3-30,G,['A' 'G'],SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3
98,7N8I,H,52,IGHV3-30,R,['S' 'R'],SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3
99,6PWU,H,26,IGHV3-30,G,['G' 'A'],"Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab",envelope glycoprotein gp160 | envelope glycoprotein gp160 | envelope glycoprotein gp160,A | C | E,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,6.2
100,6NMV,L,50,IGLV1-51,Y,['D' 'E'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
101,7SBU,H,50,IGHV1-69,R,['G' 'R'],Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.53
102,7SBU,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.53
103,7SBU,H,56,IGHV1-69,R,['T' 'I'],Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.53
104,4NHC,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,,2.912
105,4NHC,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,,2.912
106,4NHC,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41.,modified fragment of hiv glycoprotein (gp41),P,,2.912
107,7AHV,B,50,IGKV1-5,K,['D' 'K'],Anti-FIXa Fab of mim8 in complex with human FIXa,coagulation factor ix,H,homo sapiens,3.11
108,6C5V,L,50,IGLV3-21,Y,['Y' 'D'],An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus,envelope glycoprotein h | glycoprotein 42 | envelope glycoprotein l,A | C | B,human herpesvirus 4 | human herpesvirus 4 | human herpesvirus 4,4.8
109,6D2P,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens,2.6
110,6D2P,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens,2.6
111,4RFO,H,33,IGHV4-31,G,['G' 'S'],Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1,3.2
112,4RFO,L,29,IGLV2-14,G,['G' 'S'],Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1,3.2
113,4RFO,L,32,IGLV2-14,Y,['Y' 'L'],Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and M48u1,hiv-1 clade a/e gp120,G,human immunodeficiency virus 1,3.2
114,6WO4,H,33,IGHV1-69,I,['A' 'T'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.349
115,6WO4,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.349
116,6WO4,H,56,IGHV1-69,T,['T' 'I'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody HC11,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.349
117,6WO3,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.382
118,6WO3,H,73,IGHV1-69,E,['E' 'K'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody U1,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.382
119,6NMV,H,50,IGHV3-23,S,['A' 'V'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
120,6NMV,H,52,IGHV3-23,S,['S' 'Y'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
121,6NMV,H,52A,IGHV3-23,T,['G' 'S'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
122,6NMV,H,53,IGHV3-23,S,['S' 'G'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
123,6NMV,H,55,IGHV3-23,V,['G' 'S'],Non-Blocking Fab 218 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.61
124,5TE4,H,50,IGHV1-2,W,['R' 'W'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade G Strain X2088 gp120 Core,hiv-1 clade g strain x2088 gp120,G,human immunodeficiency virus 1,2.75
125,5TE4,H,61,IGHV1-2,G,['Q' 'H'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade G Strain X2088 gp120 Core,hiv-1 clade g strain x2088 gp120,G,human immunodeficiency virus 1,2.75
126,5TE4,L,32,IGKV1-13,D,['S' 'A'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade G Strain X2088 gp120 Core,hiv-1 clade g strain x2088 gp120,G,human immunodeficiency virus 1,2.75
127,6UYN,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab,hemagglutinin ha1 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus,2.85
128,6UYN,H,56,IGHV1-69,T,['T' 'I'],Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab,hemagglutinin ha1 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus,2.85
129,6UYN,H,73,IGHV1-69,D,['E' 'K'],Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab,hemagglutinin ha1 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus,2.85
130,5TE7,H,50,IGHV1-2,W,['R' 'W'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade C Strain DU172.17 gp120 Core,hiv-1 gp120 core,G,human immunodeficiency virus 1,2.15
131,5TE7,H,61,IGHV1-2,G,['Q' 'H'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade C Strain DU172.17 gp120 Core,hiv-1 gp120 core,G,human immunodeficiency virus 1,2.15
132,5TE7,L,32,IGKV1-13,D,['S' 'A'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade C Strain DU172.17 gp120 Core,hiv-1 gp120 core,G,human immunodeficiency virus 1,2.15
133,6BLH,H,31,IGHV3-33,V,['S' 'R'],RSV G central conserved region bound to Fab CB017.5,major surface glycoprotein g,G,human respiratory syncytial virus a (strainrsb6256) ,2.0
134,6BLH,H,52,IGHV3-33,W,['W' 'S'],RSV G central conserved region bound to Fab CB017.5,major surface glycoprotein g,G,human respiratory syncytial virus a (strainrsb6256) ,2.0
135,6BLH,H,94,IGHV3-33,R,['R' 'K'],RSV G central conserved region bound to Fab CB017.5,major surface glycoprotein g,G,human respiratory syncytial virus a (strainrsb6256) ,2.0
136,7CYH,E,50,IGHV3-21,E,['S' 'Y'],Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
137,5T85,H,50,IGHV3-15,R,['R' 'C'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidylglycerol (06:0 PG),10e8 epitope scaffold t117v2,G,synthetic construct,2.373
138,5T85,H,52,IGHV3-15,T,['K' 'E'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidylglycerol (06:0 PG),10e8 epitope scaffold t117v2,G,synthetic construct,2.373
139,5T85,H,52C,IGHV3-15,G,['T' 'A'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidylglycerol (06:0 PG),10e8 epitope scaffold t117v2,G,synthetic construct,2.373
140,5T85,H,53,IGHV3-15,E,['D' 'N'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidylglycerol (06:0 PG),10e8 epitope scaffold t117v2,G,synthetic construct,2.373
141,5T80,H,50,IGHV3-15,R,['R' 'C'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct,2.62
142,5T80,H,52,IGHV3-15,T,['K' 'E'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct,2.62
143,5T80,H,52C,IGHV3-15,G,['T' 'A'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct,2.62
144,5T80,H,53,IGHV3-15,E,['D' 'N'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct,2.62
145,5T80,H,58,IGHV3-15,D,['D' 'N'],Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2 and phosphatidic acid (06:0 PA),10e8 epitope scaffold t117v2,G,synthetic construct,2.62
146,7BEH,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,2.3
147,7EOW,B,52,IGHV3-23,S,['S' 'Y'],"High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine",von willebrand factor,A,homo sapiens,1.6
148,7EOW,B,52A,IGHV3-23,R,['G' 'S'],"High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine",von willebrand factor,A,homo sapiens,1.6
149,7EOW,B,53,IGHV3-23,T,['S' 'G'],"High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine",von willebrand factor,A,homo sapiens,1.6
150,2UZI,H,33,IGHV3-48,S,['S' 'E'],Crystal structure of HRAS(G12V) - anti-RAS Fv complex,gtpase hras,R,homo sapiens,2.0
151,6U36,L,69,IGKV3-11,T,['T' 'R'],PCSK9 in complex with a Fab and compound 14,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,2.7
152,4XVJ,H,50,IGHV3-23,A,['A' 'V'],STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus,2.0
153,4XVJ,H,52,IGHV3-23,S,['S' 'Y'],STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus,2.0
154,4XVJ,H,52A,IGHV3-23,S,['G' 'S'],STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus,2.0
155,4XVJ,H,53,IGHV3-23,S,['S' 'G'],STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus,2.0
156,4XVJ,L,50,IGLV1-51,D,['D' 'E'],STUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1,hcv e2 antigen,A,hepatitis c virus,2.0
157,4XVS,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),donor 45 01dg5 coree gp120,G,human immunodeficiency virus 1,1.9
158,4XVS,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of HIV-1 donor 45 d45-01dG5 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),donor 45 01dg5 coree gp120,G,human immunodeficiency virus 1,1.9
159,4XVT,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),envelope glycoprotein gp120 of hiv-1 clade a/e,G,human immunodeficiency virus 1,1.69
160,4XVT,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995),envelope glycoprotein gp120 of hiv-1 clade a/e,G,human immunodeficiency virus 1,1.69
161,7RAL,H,50,IGHV1-69,R,['G' 'R'],SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,NOT
162,7RAL,H,54,IGHV1-69,S,['F' 'L'],SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,NOT
163,7RAL,H,56,IGHV1-69,M,['T' 'I'],SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,NOT
164,7RAL,H,73,IGHV1-69,K,['E' 'K'],SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,NOT
165,5GMQ,B,33,IGHV1-69,A,['A' 'T'],Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus,2.703
166,5GMQ,B,50,IGHV1-69,R,['G' 'R'],Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus,2.703
167,5GMQ,B,54,IGHV1-69,L,['F' 'L'],Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus,2.703
168,5GMQ,B,73,IGHV1-69,K,['E' 'K'],Structure of MERS-CoV RBD in complex with a fully human antibody MCA1,s protein,A,middle east respiratory syndrome coronavirus,2.703
169,6O2C,A,33,IGHV3-49,A,['A' 'P'],Crystal structure of 4493 Fab in complex with circumsporozoite protein NANP3 and anti-kappa VHH domain,circumsporozoite protein,C,plasmodium falciparum,2.017
170,6O26,A,31,IGHV3-33,G,['S' 'R'],Crystal structure of 3246 Fab in complex with circumsporozoite protein NANA,circumsporozoite protein,C,plasmodium falciparum,1.8
171,6O26,A,52,IGHV3-33,W,['W' 'S'],Crystal structure of 3246 Fab in complex with circumsporozoite protein NANA,circumsporozoite protein,C,plasmodium falciparum,1.8
172,6O24,A,31,IGHV3-33,I,['S' 'R'],Crystal structure of 4498 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain,circumsporozoite protein,I,plasmodium falciparum,1.4
173,6O24,A,52,IGHV3-33,W,['W' 'S'],Crystal structure of 4498 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain,circumsporozoite protein,I,plasmodium falciparum,1.4
174,5F45,H,33,IGHV3-48,E,['S' 'E'],Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9),hemagglutinin ha1 chain,A,influenza a virus,4.656
175,7JWB,D,54,IGHV3-66,S,['G' 'C'],SARS CoV2 Spike ectodomain with engineered trimerized VH binder,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.2
176,7JWB,D,54,IGHV3-66,S,['G' 'C'],SARS CoV2 Spike ectodomain with engineered trimerized VH binder,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.2
177,7JWB,D,54,IGHV3-66,S,['G' 'C'],SARS CoV2 Spike ectodomain with engineered trimerized VH binder,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.2
178,6CO3,H,52,IGHV3-33,W,['W' 'S'],aducanumab abeta complex,ala-glu-phe-arg-his-asp,Q,homo sapiens,2.384
179,7MN8,D,54,IGHV3-66,N,['G' 'C'],Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab,"receptor tyrosine-protein kinase erbb-2,maltose/maltodextrin-binding periplasmic protein ",B,"homo sapiens, escherichia coli (strain k12)",3.45
180,6UCF,H,50,IGHV1-2,W,['R' 'W'],N123-VRC34_pI4 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519,hiv fusion peptide,A,human immunodeficiency virus 1,1.29
181,5VL7,H,50,IGHV3-23,R,['A' 'V'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
182,5VL7,H,52,IGHV3-23,S,['S' 'Y'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
183,5VL7,H,52A,IGHV3-23,P,['G' 'S'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
184,5VL7,H,53,IGHV3-23,A,['S' 'G'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
185,5VL7,L,30,IGKV1-13,S,['I' 'S'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
186,5VL7,L,32,IGKV1-13,A,['S' 'A'],PCSK9 complex with Fab33,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,3.5
187,5MEV,H,50,IGHV3-21,S,['S' 'Y'],MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21,"induced myeloid leukemia cell differentiation protein mcl-1homolog,induced myeloid leukemia cell differentiation protein mcl-1 ",A,"mus musculus, homo sapiens",2.94
188,5MES,H,50,IGHV3-21,S,['S' 'Y'],MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29,"induced myeloid leukemia cell differentiation protein mcl-1homolog,induced myeloid leukemia cell differentiation protein mcl-1 ",A,"mus musculus, homo sapiens",2.24
189,4M5Z,L,50,IGLV3-21,D,['Y' 'D'],"Crystal structure of broadly neutralizing antibody 5J8 bound to 2009 pandemic influenza hemagglutinin, HA1 subunit",hemagglutinin ha1 chain,A,influenza a virus,2.25
190,4HS8,H,54,IGHV3-11,D,['G' 'S'],Hepatitus C envelope glycoprotein E2 fragment 412-423 with humanized and affinity-matured antibody hu5B3.v3,e2-peptide,A,hepatitis c virus,2.6
191,4HS8,H,56,IGHV3-11,F,['T' 'Y'],Hepatitus C envelope glycoprotein E2 fragment 412-423 with humanized and affinity-matured antibody hu5B3.v3,e2-peptide,A,hepatitis c virus,2.6
192,4HS8,H,58,IGHV3-11,N,['Y' 'N'],Hepatitus C envelope glycoprotein E2 fragment 412-423 with humanized and affinity-matured antibody hu5B3.v3,e2-peptide,A,hepatitis c virus,2.6
193,7U9P,H,31,IGHV3-33,S,['S' 'R'],SARS-CoV-2 spike trimer RBD in complex with Fab NA8,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
194,7U9P,H,52,IGHV3-33,W,['W' 'S'],SARS-CoV-2 spike trimer RBD in complex with Fab NA8,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
195,7U9O,H,50,IGHV1-2,W,['R' 'W'],SARS-CoV-2 spike trimer RBD in complex with Fab NE12,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
196,7DUO,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens,2.81
197,7DUO,H,52A,IGHV3-23,G,['G' 'S'],Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens,2.81
198,7DUO,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens,2.81
199,7DUO,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of daratumumab fab and CD38 complex,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,B,homo sapiens,2.81
200,4H8W,H,52,IGHV3-23,N,['S' 'Y'],Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4.,hiv-1 clade a/e 93th057 (h375s) gp120,G,homo sapiens,1.85
201,4H8W,H,52A,IGHV3-23,N,['G' 'S'],Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4.,hiv-1 clade a/e 93th057 (h375s) gp120,G,homo sapiens,1.85
202,4H8W,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4.,hiv-1 clade a/e 93th057 (h375s) gp120,G,homo sapiens,1.85
203,4H8W,H,55,IGHV3-23,R,['G' 'S'],Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/E gp120 and sCD4.,hiv-1 clade a/e 93th057 (h375s) gp120,G,homo sapiens,1.85
204,7E9B,H,56,IGHV3-11,N,['T' 'Y'],"Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy",programmed cell death protein 1,C,homo sapiens,1.78
205,7E9B,H,58,IGHV3-11,Y,['Y' 'N'],"Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy",programmed cell death protein 1,C,homo sapiens,1.78
206,4HPY,L,50,IGLV3-10,E,['E' 'K'],Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide,envelope glycoprotein gp160,P,human immunodeficiency virus 1,1.5
207,4HPY,L,96,IGLV3-10,R,['T' 'A'],Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide,envelope glycoprotein gp160,P,human immunodeficiency virus 1,1.5
208,2PW2,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWKSL,peptide epitope,C,,2.55
209,2PW1,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWNSL,peptide epitope,C,,2.6
210,6ARU,C,31,IGHV4-4,D,['S' 'N'],Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain,epidermal growth factor receptor,A,homo sapiens,3.2
211,6ARU,C,53,IGHV4-4,S,['H' 'T'],Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain,epidermal growth factor receptor,A,homo sapiens,3.2
212,6VLN,H,31,IGHV3-33,I,['S' 'R'],Crystal structure of 4498 Fab in complex with circumsporozoite protein DND3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library,1.63
213,6VLN,H,52,IGHV3-33,W,['W' 'S'],Crystal structure of 4498 Fab in complex with circumsporozoite protein DND3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library,1.63
214,5FGC,E,50,IGHV3-23,A,['A' 'V'],Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h),1.9
215,5FGC,E,52,IGHV3-23,S,['S' 'Y'],Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h),1.9
216,5FGC,E,52A,IGHV3-23,S,['G' 'S'],Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h),1.9
217,5FGC,E,53,IGHV3-23,T,['S' 'G'],Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8,genome polyprotein,A,hepatitis c virus genotype 1a (isolate h),1.9
218,7S5P,L,50,IGLV3-21,D,['Y' 'D'],Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.86
219,5C6T,H,1,IGHV4-39,Q,['Q' 'R'],Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab,envelope glycoprotein b,A,human cytomegalovirus,3.6
220,5C6T,H,30,IGHV4-39,D,['S' 'G'],Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab,envelope glycoprotein b,A,human cytomegalovirus,3.6
221,5C6T,L,50,IGLV1-47,R,['R' 'S'],Crystal structure of HCMV glycoprotein B in complex with 1G2 Fab,envelope glycoprotein b,A,human cytomegalovirus,3.6
222,6CW2,A,54,IGHV3-66,Y,['G' 'C'],"Crystal structure of a yeast SAGA transcriptional coactivator Ada2/Gcn5 HAT subcomplex, crystal form 1",histone acetyltransferase gcn5 | transcriptional adapter 2,D | C,saccharomyces cerevisiae | saccharomyces cerevisiae,2.67
223,2CMR,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
224,2CMR,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
225,2CMR,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
226,2CMR,H,56,IGHV1-69,T,['T' 'I'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
227,2CMR,H,73,IGHV1-69,E,['E' 'K'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
228,2CMR,L,50,IGKV1-5,K,['D' 'K'],Crystal structure of the HIV-1 neutralizing antibody D5 Fab bound to  the gp41 inner-core mimetic 5-helix,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.0
229,5BVP,H,31,IGHV3-33,V,['S' 'R'],"The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",interleukin-1 beta,I,homo sapiens,2.2
230,5BVP,H,52,IGHV3-33,W,['W' 'S'],"The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",interleukin-1 beta,I,homo sapiens,2.2
231,5BVP,H,94,IGHV3-33,R,['R' 'K'],"The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1beta",interleukin-1 beta,I,homo sapiens,2.2
232,4XMM,H,54,IGHV3-66,Y,['G' 'C'],"Structure of the yeast coat nucleoporin complex, space group C2",nucleoporin nup85 | nucleoporin seh1,D | C,saccharomyces cerevisiae s288c | saccharomyces cerevisiae s288c,7.384
233,2XTJ,B,30,IGKV1-13,R,['I' 'S'],The crystal structure of PCSK9 in complex with 1D05 Fab,proprotein convertase subtilisin/kexin type 9,A,homo sapiens,2.7
234,2XTJ,D,54,IGHV1-69,L,['F' 'L'],The crystal structure of PCSK9 in complex with 1D05 Fab,proprotein convertase subtilisin/kexin type 9,A,homo sapiens,2.7
235,2XTJ,D,56,IGHV1-69,I,['T' 'I'],The crystal structure of PCSK9 in complex with 1D05 Fab,proprotein convertase subtilisin/kexin type 9,A,homo sapiens,2.7
236,7XH8,B,34,IGHV1-58,S,['V' 'M'],The structure of ZCB11 Fab against SARS-CoV-2 Omicron Spike,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.99
237,8GV5,C,52,IGHV3-30,S,['S' 'R'],Crystal structure of PN-SIA28 in complex with influenza hemagglutinin A/swine/Guangdong/104/2013 (H1N1),hemagglutinin ha2 chain | hemagglutinin ha1 chain,B | A,influenza a virus(a/swine/guangdong/104/2013(h1n1))  | influenza a virus(a/swine/guangdong/104/2013(h1n1)) ,3.2
238,8GV7,C,52,IGHV3-30,S,['S' 'R'],Crystal structure of PN-SIA28 in complex with influenza hemagglutinin H18 A/flat-faced bat/Peru/033/2010,hemagglutinin h18-ha2 | hemagglutinin h18-ha1,B | A,influenza a virus (a/flat-facedbat/peru/033/2010(h18n11))  | influenza a virus (a/flat-facedbat/peru/033/2010(h18n11)) ,2.6
239,4S1Q,H,50,IGHV1-2,W,['R' 'W'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core",hiv-1 gp120 core,G,homo sapiens,2.4
240,4S1Q,H,61,IGHV1-2,R,['Q' 'H'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core",hiv-1 gp120 core,G,homo sapiens,2.4
241,4S1Q,H,69,IGHV1-2,M,['S' 'M'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H03+06.D-001739, in complex with clade A/E HIV-1 gp120 core",hiv-1 gp120 core,G,homo sapiens,2.4
242,4S1R,H,50,IGHV1-2,W,['R' 'W'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H08.F-117225, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.214
243,4S1R,H,61,IGHV1-2,R,['Q' 'H'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H08.F-117225, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.214
244,4S1S,H,50,IGHV1-2,W,['R' 'W'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H5.F-185917, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.39
245,4S1S,H,61,IGHV1-2,R,['Q' 'H'],"Crystal structure of a VRC01-lineage antibody, 45-VRC01.H5.F-185917, in complex with clade A/E HIV-1 gp120 core",clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,3.39
246,7E3O,H,26,IGHV3-30,G,['G' 'A'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.51
247,7E3O,H,94,IGHV3-30,R,['R' 'K'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.51
248,3SE9,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1,2.0
249,3SE9,H,61,IGHV1-2,P,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1,2.0
250,5J13,B,50,IGLV3-21,D,['Y' 'D'],Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens,2.298
251,5J13,C,31,IGHV3-33,T,['S' 'R'],Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens,2.298
252,5J13,C,52,IGHV3-33,W,['W' 'S'],Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens,2.298
253,5J13,C,94,IGHV3-33,R,['R' 'K'],Cytokine antibody complex,thymic stromal lymphopoietin,A,homo sapiens,2.298
254,4AL8,L,30,IGKV1-17,R,['R' 'S'],Structure of Dengue virus DIII in complex with Fab 2H12,envelope protein,C,dengue virus,1.66
255,4AL8,L,32,IGKV1-17,S,['D' 'Y'],Structure of Dengue virus DIII in complex with Fab 2H12,envelope protein,C,dengue virus,1.66
256,5C0S,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261,"hemagglutinin, envelope glycoprotein, fibritin fusionprotein ",A,"influenza a virus, human immunodeficiency virustype 1 group m subtype b, enterobacteria phage t4 ",4.3
257,5C0S,H,56,IGHV1-69,T,['T' 'I'],Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the broadly neutralizing antibody CR6261,"hemagglutinin, envelope glycoprotein, fibritin fusionprotein ",A,"influenza a virus, human immunodeficiency virustype 1 group m subtype b, enterobacteria phage t4 ",4.3
258,4DN4,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of the complex between cnto888 fab and mcp-1 mutant p8a,c-c motif chemokine 2,M,homo sapiens,2.8
259,4JPW,H,50,IGHV1-2,L,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain 93th057 gp120 mutant,hiv-1 clade a/e strain 73th057 gp120 with mutation h375s,G,human immunodeficiency virus 1,2.904
260,4JPW,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain 93th057 gp120 mutant,hiv-1 clade a/e strain 73th057 gp120 with mutation h375s,G,human immunodeficiency virus 1,2.904
261,2HFG,H,54,IGHV3-66,V,['G' 'C'],Crystal structure of hBR3 bound to CB3s-Fab,tumor necrosis factor receptor superfamily member 13c,R,homo sapiens,2.61
262,7T01,H,54,IGHV2-5,D,['N' 'D'],SARS-CoV-2 S-RBD + Fab 54042-4,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.69
263,7LY0,H,31,IGHV3-33,S,['S' 'R'],SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.6
264,7LY0,H,35,IGHV3-33,H,['H' 'Y'],SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.6
265,7LY0,H,52,IGHV3-33,W,['W' 'S'],SARS-CoV-2 S/S2M11/S2M28 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.6
266,4J6R,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120,envelope glycoprotein gp160,G,human immunodeficiency virus 1,1.64
267,4J6R,H,61,IGHV1-2,P,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC23 in complex with HIV-1 gp120,envelope glycoprotein gp160,G,human immunodeficiency virus 1,1.64
268,3U7Y,H,50,IGHV1-2,W,['R' 'W'],Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV,envelope glycoprotein gp160,G,human immunodeficiency virus 1,2.4478
269,3U7Y,H,61,IGHV1-2,R,['Q' 'H'],Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV,envelope glycoprotein gp160,G,human immunodeficiency virus 1,2.4478
270,3U7Y,H,69,IGHV1-2,M,['S' 'M'],Structure of NIH45-46 Fab in complex with gp120 of 93TH057 HIV,envelope glycoprotein gp160,G,human immunodeficiency virus 1,2.4478
271,3MLZ,H,30,IGHV4-59,S,['S' 'Y'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
272,3MLZ,H,31,IGHV4-59,G,['S' 'Y'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
273,3MLZ,H,32,IGHV4-59,F,['Y' 'W' 'H'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
274,3MLZ,H,33,IGHV4-59,H,['Y' 'S'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
275,3MLZ,H,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
276,3MLZ,L,50,IGLV1-51,E,['D' 'E'],Crystal structure of anti-HIV-1 V3 Fab 3074 in complex with a VI191 V3 peptide,hiv-1 gp120 third variable region (v3) crown,P,human immunodeficiency virus 1,2.99
277,6IUT,H,31,IGHV4-4,S,['S' 'N'],Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1)),2.3
278,6IUT,H,50,IGHV4-4,Y,['E' 'R' 'Y'],Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1)),2.3
279,6IUT,H,53,IGHV4-4,D,['H' 'T'],Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1)),2.3
280,6IUT,H,73,IGHV4-4,T,['K' 'T'],Crystal structure of influenza A virus H5 hemagglutinin globular head in complex with the Fab of antibody AVFluIgG01,hemagglutinin,A,influenza a virus (a/anhui/1/2005(h5n1)),2.3
281,7ND3,H,54,IGHV3-66,G,['G' 'C'],EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.7
282,7V27,A,29,IGLV2-14,A,['G' 'S'],RBD/XG005 local refinement,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
283,7V27,A,32,IGLV2-14,Y,['Y' 'L'],RBD/XG005 local refinement,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
284,7V27,B,54,IGHV2-5,D,['N' 'D'],RBD/XG005 local refinement,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
285,7OX3,A,32,IGHV4-30-4,R,['G' 'Y'],Fab 6D3: hIL-9 complex,interleukin-9,C,homo sapiens,1.7
286,7OX3,A,35,IGHV4-30-4,A,['Y' 'S'],Fab 6D3: hIL-9 complex,interleukin-9,C,homo sapiens,1.7
287,7SD5,H,1,IGHV4-39,Q,['Q' 'R'],Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.53
288,7SD5,H,26,IGHV4-39,G,['G' 'S'],Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.53
289,7SD5,H,27,IGHV4-39,G,['G' 'Y'],Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.53
290,7SD5,H,28,IGHV4-39,S,['S' 'Y'],Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.53
291,7OXN,H,31,IGHV3-33,S,['S' 'R'],Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,2.5
292,7OXN,H,35,IGHV3-33,H,['H' 'Y'],Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,2.5
293,7OXN,H,52,IGHV3-33,W,['W' 'S'],Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,2.5
294,7T72,H,54,IGHV3-66,G,['G' 'C'],Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.177
295,7T73,H,52C,IGHV3-15,T,['T' 'A'],HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab,hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.0
296,7T73,H,53,IGHV3-15,D,['D' 'N'],HIV-1 Envelope ApexGT2.2MUT in complex with PCT64.LMCA Fab,hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120 | hiv envelope apexgt2.2mut gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.0
297,7T76,H,26,IGHV3-30,G,['G' 'A'],HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab,hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.43
298,7T76,H,94,IGHV3-30,R,['R' 'K'],HIV-1 Envelope ApexGT3 in complex with PG9.iGL Fab,hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120 | hiv envelope apexgt3 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.43
299,7T77,H,26,IGHV3-30,G,['G' 'A'],HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab,hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.75
300,7T77,H,52,IGHV3-30,K,['S' 'R'],HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab,hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120 | hiv envelope apexgt3.n130 gp120,E | A | C,human immunodeficiency virus 1 | human immunodeficiency virus 1 | human immunodeficiency virus 1,4.75
301,6DB6,H,51,IGHV1-3,I,['I' 'S'],Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain,hiv-1 gp120 v3 peptide from mn strain,P,human immunodeficiency virus 1,1.978
302,6DB6,L,50,IGLV3-10,E,['E' 'K'],Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain,hiv-1 gp120 v3 peptide from mn strain,P,human immunodeficiency virus 1,1.978
303,6DB6,L,96,IGLV3-10,Y,['T' 'A'],Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain,hiv-1 gp120 v3 peptide from mn strain,P,human immunodeficiency virus 1,1.978
304,7KQL,H,30,IGHV4-39,S,['S' 'G'],Anti-Tim3 antibody Fab complex,hepatitis a virus cellular receptor 2,T,homo sapiens,1.49
305,3N85,H,58,IGHV3-74,S,['S' 'T'],Crystallographic trimer of HER2 extracellular regions in complex with tryptophan-rich antibody fragment,receptor tyrosine-protein kinase erbb-2,A,homo sapiens,3.2
306,6WG0,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of Fab366 in complex with NPNA3 peptide from circumsporozoite protein,npna3 peptide,P,plasmodium falciparum,1.599
307,6WGL,A,50,IGHV3-23,S,['A' 'V'],Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor,interleukin-4 receptor subunit alpha,C,homo sapiens,2.82
308,6WGL,A,52,IGHV3-23,S,['S' 'Y'],Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor,interleukin-4 receptor subunit alpha,C,homo sapiens,2.82
309,6WGL,A,53,IGHV3-23,S,['S' 'G'],Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor,interleukin-4 receptor subunit alpha,C,homo sapiens,2.82
310,7MDP,H,26,IGHV4-4,G,['G' 'S'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
311,7MDP,H,27,IGHV4-4,G,['G' 'I'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
312,7MDP,H,31,IGHV4-4,S,['S' 'N'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
313,7MDP,H,32,IGHV4-4,S,['S' 'W' 'Y'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
314,7MDP,H,33,IGHV4-4,N,['N' 'W' 'Y'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
315,7MDP,H,53,IGHV4-4,H,['H' 'T'],KRas G12C in complex with G-2897,isoform 2b of gtpase kras,A,homo sapiens,1.96
316,6XZW,L,60,IGKV3-20,D,['D' 'A'],Crystal structure of the meningococcal vaccine antigen fHbp in complex with a cross-reactive human Fab.,lipoprot_c domain-containing protein,D,neisseria meningitidis serogroup b (strainmc58) ,2.4
317,4XI5,D,33,IGHV3-30,A,['A' 'G'],gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine,3.9
318,4XI5,D,50,IGHV3-30,V,['V' 'F'],gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine,3.9
319,4XI5,D,52,IGHV3-30,S,['S' 'R'],gHgL of varicella-zoster virus in complex with human neutralizing antibodies,envelope glycoprotein l | envelope glycoprotein h,B | A,human herpesvirus 3 strain oka vaccine | human herpesvirus 3 strain oka vaccine,3.9
320,7ZR8,H,33,IGHV1-69,T,['A' 'T'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
321,7ZR8,H,50,IGHV1-69,R,['G' 'R'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
322,7ZR8,H,54,IGHV1-69,A,['F' 'L'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
323,7ZR8,H,56,IGHV1-69,K,['T' 'I'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
324,7ZR8,H,73,IGHV1-69,K,['E' 'K'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
325,7ZR8,L,50,IGKV1-5,D,['D' 'K'],OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement),"spike glycoprotein,fibritin",A,"severe acute respiratory syndrome coronavirus2, enterobacteria phage t4 ",3.7
326,7R7N,H,54,IGHV1-69,V,['F' 'L'],SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106),spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,3.95
327,7B3O,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,2.0
328,6VJT,H,31,IGHV3-33,R,['S' 'R'],Co-crystals of broadly neutralizing antibody with the linear epitope from Hepatitis B surface antigen,antigenic region 139-148 of hepatitis b surface antigenprotein ,P,hepatitis b virus,1.782
329,6VJT,H,52,IGHV3-33,W,['W' 'S'],Co-crystals of broadly neutralizing antibody with the linear epitope from Hepatitis B surface antigen,antigenic region 139-148 of hepatitis b surface antigenprotein ,P,hepatitis b virus,1.782
330,6ULF,A,31,IGHV3-33,I,['S' 'R'],Crystal structure of 4498 Fab in complex with circumsporozoite protein NDN3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library,1.7
331,6ULF,A,52,IGHV3-33,W,['W' 'S'],Crystal structure of 4498 Fab in complex with circumsporozoite protein NDN3 and anti-Kappa VHH domain,circumsporozoite protein | anti kappa vhh domain,P | K,plasmodium falciparum | camelidae mixed library,1.7
332,6ULC,H,26,IGHV3-30,G,['G' 'A'],"Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom","envelope glycoprotein gp120,envelope glycoprotein gp120 | envelope glycoprotein gp120,envelope glycoprotein gp120",A | E,human immunodeficiency virus 1 | human immunodeficiency virus 1,4.6
333,7YKJ,A,53,IGHV3-23,T,['S' 'G'],Omicron RBDs bound with P3E6 Fab (one up and one down),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
334,7YKJ,D,60,IGKV3-20,D,['D' 'A'],Omicron RBDs bound with P3E6 Fab (one up and one down),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
335,7T5O,L,50,IGLV3-21,D,['Y' 'D'],VFLIP Spike Trimer with GAR03,spike glycoprotein,C,severe acute respiratory syndrome-relatedcoronavirus ,0
336,7M71,H,33,IGHV3-30,E,['A' 'G'],SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,2.66
337,7M71,H,50,IGHV3-30,V,['V' 'F'],SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,2.66
338,7M71,H,52,IGHV3-30,S,['S' 'R'],SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,2.66
339,7M71,H,94,IGHV3-30,R,['R' 'K'],SARS-CoV-2 Spike:5A6 Fab complex I focused refinement,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,2.66
340,6MLK,H,30,IGHV4-34,S,['S' 'Y'],Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea,2.45
341,6MLK,H,31,IGHV4-34,G,['G' 'W'],Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea,2.45
342,6MLK,H,32,IGHV4-34,Y,['Y' 'S'],Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea,2.45
343,6MLK,H,52,IGHV4-34,N,['N' 'Y' 'I'],Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea,2.45
344,6MLK,H,53,IGHV4-34,H,['H' 'Y'],Structure of Thioesterase from DEBS with a thioesterase-specific antibody,"6-deoxyerythronolide-b synthase erya3, modules 5 and 6",A,saccharopolyspora erythraea,2.45
345,7D5B,D,58,IGHV3-74,T,['S' 'T'],"BACE2 xaperone complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide",beta-secretase 2,A,homo sapiens,1.31
346,7D5U,D,58,IGHV3-74,T,['S' 'T'],"BACE2 xaperone complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide",beta-secretase 2,A,homo sapiens,2.04
347,7EY4,H,56,IGHV3-11,A,['T' 'Y'],Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667,spike glycoprotein | ntd,R | N,severe acute respiratory syndrome coronavirus2  | homo sapiens,3.69
348,7EY4,H,58,IGHV3-11,Y,['Y' 'N'],Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667,spike glycoprotein | ntd,R | N,severe acute respiratory syndrome coronavirus2  | homo sapiens,3.69
349,6E4X,Z,32,IGHV4-61,N,['G' 'S' 'Y'],Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2),hemagglutinin,B,influenza a virus (a/texas/50/2012(h3n2)),2.25
350,6E4X,Z,33,IGHV4-61,I,['S' 'Y' 'G'],Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2),hemagglutinin,B,influenza a virus (a/texas/50/2012(h3n2)),2.25
351,6E4X,Z,34,IGHV4-61,Y,['Y' 'W'],Human antibody S5V2-29 in complex with influenza hemagglutinin A/Texas/50/2012 (H3N2),hemagglutinin,B,influenza a virus (a/texas/50/2012(h3n2)),2.25
352,2EKS,B,27,IGHV4-59,D,['G' 'I'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
353,2EKS,B,30,IGHV4-59,R,['S' 'Y'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
354,2EKS,B,31,IGHV4-59,S,['S' 'Y'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
355,2EKS,B,32,IGHV4-59,D,['Y' 'W' 'H'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
356,2EKS,B,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
357,2EKS,B,50,IGHV4-59,Y,['Y' 'R'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
358,2EKS,B,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
359,2EKS,B,58,IGHV4-59,Y,['N' 'Y'],Crystal structure of humanized HyHEL-10 FV-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.0
360,7SJS,H,50,IGHV3-23,A,['A' 'V'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
361,7SJS,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
362,7SJS,H,53,IGHV3-23,G,['S' 'G'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
363,7SJS,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
364,7SJS,L,50,IGLV3-10,E,['E' 'K'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
365,7SJS,L,96,IGLV3-10,A,['T' 'A'],Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8,stem helix peptide of spike protein s2',C,severe acute respiratory syndrome coronavirus2 ,1.612
366,4OT1,L,50,IGLV1-51,D,['D' 'E'],Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by the Neutralizing Human Antibody SM5-1,envelope glycoprotein b,A,human cytomegalovirus,2.11
367,7VNG,L,90,IGKV1-39,Q,['Q' 'C'],Crystal structure of human coronavirus 229E spike protein receptor-binding domain in complex with S11 Fab,spike glycoprotein s1,D,human coronavirus 229e,3.8
368,4HHA,B,33,IGHV3-30,G,['A' 'G'],Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5,1.6
369,4HHA,B,52,IGHV3-30,S,['S' 'R'],Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5,1.6
370,4HHA,B,94,IGHV3-30,R,['R' 'K'],Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1,glycoprotein b,P,human herpesvirus 5,1.6
371,6PZE,L,50,IGLV1-51,D,['D' 'E'],Crystal structure of human NA-45 Fab in complex with neuraminidase Y169aH mutant from A/Shanghai/2/2013 (H7N9),neuraminidase,A,influenza a virus (a/shanghai/02/2013(h7n9)),2.3
372,6B0G,C,27D,IGKV2-30,Y,['Y' 'H'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1245,25 kda ookinete surface antigen,E,plasmodium falciparum,1.9
373,6B0A,H,50,IGHV3-23,T,['A' 'V'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum,2.5
374,6B0A,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum,2.5
375,6B0A,H,52A,IGHV3-23,G,['G' 'S'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum,2.5
376,6B0A,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum,2.5
377,6B0A,H,55,IGHV3-23,D,['G' 'S'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1269,25 kda ookinete surface antigen,A,plasmodium falciparum,2.5
378,6B08,B,50,IGLV3-21,Y,['Y' 'D'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1276,pfs25,A,plasmodium falciparum,2.2
379,6B08,C,50,IGHV1-2,W,['R' 'W'],Crystal structure of Pfs25 in complex with the transmission blocking antibody 1276,pfs25,A,plasmodium falciparum,2.2
380,7MF1,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.092
381,7MF1,H,73,IGHV1-69,E,['E' 'K'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.092
382,7MF1,L,32,IGLV2-14,F,['Y' 'L'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.092
383,7MF1,L,50,IGLV2-14,D,['E' 'D'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.092
384,6AOD,A,30,IGKV1-17,R,['R' 'S'],FXIa antibody complex,coagulation factor xi,C,homo sapiens,1.8
385,6AOD,A,32,IGKV1-17,D,['D' 'Y'],FXIa antibody complex,coagulation factor xi,C,homo sapiens,1.8
386,6AOD,A,34,IGKV1-17,G,['G' 'A'],FXIa antibody complex,coagulation factor xi,C,homo sapiens,1.8
387,6AOD,B,50,IGHV1-2,W,['R' 'W'],FXIa antibody complex,coagulation factor xi,C,homo sapiens,1.8
388,6AOD,B,61,IGHV1-2,Q,['Q' 'H'],FXIa antibody complex,coagulation factor xi,C,homo sapiens,1.8
389,3PGF,H,54,IGHV3-11,S,['G' 'S'],Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB),maltose-binding periplasmic protein,A,escherichia coli,2.1
390,3PGF,H,56,IGHV3-11,Y,['T' 'Y'],Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB),maltose-binding periplasmic protein,A,escherichia coli,2.1
391,6FGB,H,26,IGHV3-30,G,['G' 'A'],Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.9
392,6FGB,L,30,IGKV1-17,K,['R' 'S'],Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.9
393,6FGB,L,32,IGKV1-17,Y,['D' 'Y'],Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.9
394,6FGB,L,34,IGKV1-17,Y,['G' 'A'],Human FcRn extra-cellular domain complexed with Fab fragment of Rozanolixizumab,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.9
395,3GRW,H,52,IGHV3-23,Y,['S' 'Y'],FGFR3 in complex with a Fab,fibroblast growth factor receptor 3,A,homo sapiens,2.1
396,3GRW,H,52A,IGHV3-23,P,['G' 'S'],FGFR3 in complex with a Fab,fibroblast growth factor receptor 3,A,homo sapiens,2.1
397,7VNC,V,52,IGHV3-23,Y,['S' 'Y'],"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)",spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,3.7
398,7VNC,V,53,IGHV3-23,H,['S' 'G'],"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)",spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,3.7
399,7VNC,V,60,IGHV3-23,N,['A' 'G'],"Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)",spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,3.7
400,7VNB,A,52,IGHV3-23,Y,['S' 'Y'],Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113,spike protein s1,B,severe acute respiratory syndrome coronavirus2 ,2.27
401,7VNB,A,60,IGHV3-23,N,['A' 'G'],Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113,spike protein s1,B,severe acute respiratory syndrome coronavirus2 ,2.27
402,7VNG,H,54,IGHV3-66,Y,['G' 'C'],Crystal structure of human coronavirus 229E spike protein receptor-binding domain in complex with S11 Fab,spike glycoprotein s1,D,human coronavirus 229e,3.8
403,5CIN,H,33,IGHV1-69,A,['A' 'T'],Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1,1.7
404,5CIN,H,50,IGHV1-69,G,['G' 'R'],Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1,1.7
405,5CIN,H,54,IGHV1-69,L,['F' 'L'],Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1,1.7
406,5CIN,H,56,IGHV1-69,I,['T' 'I'],Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound,peptide from mper region of hiv-1 env,P,human immunodeficiency virus 1,1.7
407,5CIL,H,33,IGHV1-69,A,['A' 'T'],Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1,1.81
408,5CIL,H,50,IGHV1-69,G,['G' 'R'],Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1,1.81
409,5CIL,H,54,IGHV1-69,L,['F' 'L'],Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1,1.81
410,5CIL,H,56,IGHV1-69,I,['T' 'I'],Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound,peptide from the mper region of the env protein of hiv-1,P,human immunodeficiency virus 1,1.81
411,6VJN,H,31,IGHV4-59,D,['S' 'Y'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
412,6VJN,H,32,IGHV4-59,Y,['Y' 'W' 'H'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
413,6VJN,H,33,IGHV4-59,W,['Y' 'S'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
414,6VJN,H,50,IGHV4-59,R,['Y' 'R'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
415,6VJN,H,53,IGHV4-59,S,['Y' 'T'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
416,6VJN,H,58,IGHV4-59,Y,['N' 'Y'],Structure of NHP D11A.B5Fab in complex with 16055 V2b peptide,v2b peptide | v2b peptide,G | F,homo sapiens | homo sapiens,2.0
417,7FCQ,L,50,IGLV2-14,E,['E' 'D'],Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.89
418,7FCQ,L,53,IGLV2-14,D,['N' 'K'],Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.89
419,7F63,H,51,IGHV1-3,N,['I' 'S'],Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refinement of S-RBD and chAb-45 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
420,7F62,H,56,IGHV3-11,Y,['T' 'Y'],Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.6
421,7F62,H,58,IGHV3-11,N,['Y' 'N'],Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.6
422,7F62,L,96,IGKV3D-20,Y,['Y' 'R'],Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.6
423,5GGT,H,54,IGHV1-69,F,['F' 'L'],PD-L1 in complex with BMS-936559 Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.8
424,5GGT,H,56,IGHV1-69,K,['T' 'I'],PD-L1 in complex with BMS-936559 Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.8
425,5GGV,H,52,IGHV3-33,W,['W' 'S'],CTLA-4 in complex with tremelimumab Fab,cytotoxic t-lymphocyte protein 4,Y,homo sapiens,1.998
426,2WUC,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of HGFA in complex with the allosteric non- inhibitory antibody Fab40.deltaTrp and Ac-KQLR-chloromethylketone,hepatocyte growth factor activator long chain,A,homo sapiens,2.7
427,6DF1,H,50,IGHV3-23,G,['A' 'V'],anti-phosphotyrosine antibody 4G10-4D5 Fab complexed with sulfate,leu-ptr,A,synthetic construct,2.3
428,6DF1,H,52,IGHV3-23,N,['S' 'Y'],anti-phosphotyrosine antibody 4G10-4D5 Fab complexed with sulfate,leu-ptr,A,synthetic construct,2.3
429,6DFI,H,31,IGHV4-59,T,['S' 'Y'],Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus,2.48
430,6DFI,H,32,IGHV4-59,Y,['Y' 'W' 'H'],Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus,2.48
431,6DFI,H,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus,2.48
432,6DFI,H,58,IGHV4-59,H,['N' 'Y'],Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII,zika virus envelope protein diii,E,zika virus,2.48
433,6DFJ,H,27,IGHV4-59,G,['G' 'I'],Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1,2.07
434,6DFJ,H,31,IGHV4-59,T,['S' 'Y'],Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1,2.07
435,6DFJ,H,32,IGHV4-59,Y,['Y' 'W' 'H'],Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1,2.07
436,6DFJ,H,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1,2.07
437,6DFJ,H,58,IGHV4-59,H,['N' 'Y'],Crystal structure of anti-Zika antibody Z021 bound to DENV-1 envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus 1,2.07
438,7LSS,H,54,IGHV2-5,D,['N' 'D'],Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.72
439,7LSS,L,29,IGLV2-14,A,['G' 'S'],Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.72
440,7LSS,L,32,IGLV2-14,Y,['Y' 'L'],Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.72
441,7LSS,L,50,IGLV2-14,D,['E' 'D'],Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.72
442,1U8P,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ECDKWCS,gp41 peptide,C,human immunodeficiency virus 1,3.23
443,1U8Q,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELEKWAS,gp41 peptide,C,human immunodeficiency virus 1,2.24
444,1U8Q,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELEKWAS,gp41 peptide,C,human immunodeficiency virus 1,2.24
445,1U8J,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWAG,gp41 peptide,C,human immunodeficiency virus 1,2.24
446,1U8K,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LELDKWASL,gp41 peptide,C,human immunodeficiency virus 1,2.24
447,1U8H,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWAS,gp41 peptide,C,human immunodeficiency virus 1,2.1
448,1U8I,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKWAN,gp41 peptide,C,human immunodeficiency virus 1,2.0
449,1U8N,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKFAS,gp41 peptide,C,human immunodeficiency virus 1,2.56
450,1U8O,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKHAS,gp41 peptide,C,human immunodeficiency virus 1,3.02
451,1U8O,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKHAS,gp41 peptide,C,human immunodeficiency virus 1,3.02
452,1U8L,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide DLDRWAS,gp41 peptide,C,human immunodeficiency virus 1,2.6
453,7SN2,H,52,IGHV3-33,W,['W' 'S'],Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4.3
454,6OZ2,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of the broadly neutralizing antibody N49P6 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.55
455,6OZ2,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of the broadly neutralizing antibody N49P6 Fab in complex with HIV-1 Clade A/E strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.55
456,7WBZ,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.42
457,4R8W,L,60,IGKV3-20,D,['D' 'A'],Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a neutralizing antibody CT149,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/anhui/1-balf_rg45/2013(h7n9))  | influenza a virus (a/anhui/1-balf_rg45/2013(h7n9)) ,2.795
458,5HHV,H,52,IGHV3-23,S,['S' 'Y'],Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens,2.2
459,5HHV,H,53,IGHV3-23,S,['S' 'G'],Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens,2.2
460,5HHV,H,55,IGHV3-23,G,['G' 'S'],Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens,2.2
461,5HHX,H,53,IGHV3-23,S,['S' 'G'],Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens,3.0
462,5HHX,H,55,IGHV3-23,G,['G' 'S'],Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide,interleukin-17a,A,homo sapiens,3.0
463,6FAX,H,50,IGHV1-2,G,['R' 'W'],Complex of Human CD40 Ectodomain with Lob 7.4 Fab,tumor necrosis factor receptor superfamily member 5,R,homo sapiens,2.99
464,1U8M,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDKYAS,gp41 peptide,C,human immunodeficiency virus 1,2.4
465,2B1H,L,50,IGLV1-47,R,['R' 'S'],Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with UG29 peptide,ug29 peptide of exterior membrane glycoprotein gp120,P,,2.0
466,5Y2L,I,26,IGHV3-30,G,['G' 'A'],Crystal structure of a group 2 HA binding antibody AF4H1K1 Fab in complex with the 1968 H3N2 pandemic (H3-AC/68) hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (strain a/aichi/2/1968 h3n2) | influenza a virus (strain a/aichi/2/1968 h3n2),2.902
467,2EIZ,B,27,IGHV4-59,D,['G' 'I'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
468,2EIZ,B,30,IGHV4-59,R,['S' 'Y'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
469,2EIZ,B,31,IGHV4-59,S,['S' 'Y'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
470,2EIZ,B,32,IGHV4-59,D,['Y' 'W' 'H'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
471,2EIZ,B,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
472,2EIZ,B,50,IGHV4-59,Y,['Y' 'R'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
473,2EIZ,B,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
474,2EIZ,B,58,IGHV4-59,Y,['N' 'Y'],Crystal structure of humanized HYHEL-10 fv mutant(HW47Y)-hen lysozyme complex,lysozyme c,C,gallus gallus,1.9
475,7FG2,D,50,IGHV3-23,T,['A' 'V'],"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4.4
476,7FG2,D,52,IGHV3-23,S,['S' 'Y'],"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4.4
477,7FG2,D,60,IGHV3-23,G,['A' 'G'],"Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4.4
478,7FG3,D,50,IGHV3-23,T,['A' 'V'],"Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
479,7FG3,D,52,IGHV3-23,S,['S' 'Y'],"Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
480,7Z0Y,H,33,IGHV3-30,A,['A' 'G'],THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.95
481,7Z0Y,H,50,IGHV3-30,V,['V' 'F'],THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.95
482,7Z0Y,H,52,IGHV3-30,S,['S' 'R'],THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.95
483,4G7V,L,30,IGKV1-13,S,['I' 'S'],"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.5 A)",voltage-sensor containing phosphatase,S,ciona intestinalis,2.5
484,4G7V,L,32,IGKV1-13,A,['S' 'A'],"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.5 A)",voltage-sensor containing phosphatase,S,ciona intestinalis,2.5
485,4NGH,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,,2.68
486,4NGH,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,,2.68
487,4NGH,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,,2.68
488,4NGH,H,73,IGHV1-69,R,['E' 'K'],Crystal structure of the HIV-1 neutralizing antibody 4E10 Fab fragment in complex with a hydrocarbon-stapled peptide containing the 4e10 epitope on gp41 and a tethered phosphate moiety.,modified fragment of hiv glycoprotein (gp41),P,,2.68
489,4JKP,H,50,IGHV1-2,W,['R' 'W'],Restricting HIV-1 Pathways for Escape using Rationally-Designed Anti-HIV-1 Antibodies,gp120,G,human immunodeficiency virus 1,2.82
490,4JKP,H,61,IGHV1-2,R,['Q' 'H'],Restricting HIV-1 Pathways for Escape using Rationally-Designed Anti-HIV-1 Antibodies,gp120,G,human immunodeficiency virus 1,2.82
491,7RU4,H,33,IGHV1-69,A,['A' 'T'],CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
492,7RU4,H,54,IGHV1-69,L,['F' 'L'],CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
493,7RU4,H,56,IGHV1-69,I,['T' 'I'],CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
494,7RU4,H,73,IGHV1-69,K,['E' 'K'],CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
495,6CBV,H,54,IGHV3-48,S,['S' 'G'],Crystal strutcure of BRIL bound to an affinity matured synthetic antibody.,bril,B,escherichia coli,1.872
496,6CBV,L,50,IGKV1-5,S,['D' 'K'],Crystal strutcure of BRIL bound to an affinity matured synthetic antibody.,bril,B,escherichia coli,1.872
497,5X08,H,33,IGHV1-69,A,['A' 'T'],"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) ,1.49
498,5X08,H,50,IGHV1-69,G,['G' 'R'],"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) ,1.49
499,5X08,H,54,IGHV1-69,L,['F' 'L'],"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) ,1.49
500,5X08,H,56,IGHV1-69,I,['T' 'I'],"Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound",envelope glycoprotein gp160,P,human immunodeficiency virus type 1 (malisolate) ,1.49
501,7LQW,H,54,IGHV1-69,F,['F' 'L'],Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,4.47
502,7LQW,H,56,IGHV1-69,T,['T' 'I'],Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike,spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,4.47
503,7TAS,H,52A,IGHV3-43,W,['W' 'G'],SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146),spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,3.2
504,5L6Y,L,50,IGLV3-21,D,['Y' 'D'],il13 in complex with tralokinumab,interleukin-13,C,homo sapiens,1.99
505,3P0Y,H,58,IGHV3-74,D,['S' 'T'],anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region,epidermal growth factor receptor,A,homo sapiens,1.8
506,8DWA,H,33,IGHV1-69,S,['A' 'T'],Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.2
507,8DWA,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.2
508,8DWA,H,54,IGHV1-69,I,['F' 'L'],Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.2
509,8DWA,H,56,IGHV1-69,K,['T' 'I'],Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.2
510,5UWE,H,54,IGHV1-69,F,['F' 'L'],"CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1",clade a/e 93th057 hiv-1 gp120 core | m48u1 cd4 mimetic peptide,G | N,human immunodeficiency virus 1 | synthetic construct,3.19
511,4G7Y,L,30,IGKV1-13,S,['I' 'S'],"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.8 A)",voltage-sensor containing phosphatase,S,ciona intestinalis,2.8
512,4G7Y,L,32,IGKV1-13,A,['S' 'A'],"Crystal structure of voltage sensing domain of Ci-VSP with fragment antibody (R217E, 2.8 A)",voltage-sensor containing phosphatase,S,ciona intestinalis,2.8
513,4DAG,H,54,IGHV3-66,G,['G' 'C'],Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneumovirus Antigenic Site,fusion glycoprotein f0,A,human metapneumovirus,3.3904
514,7WP5,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 Omicron S6P trimer in complex with neutralizing antibody VacW-209 (local refinement),spikeprotein s1,F,severe acute respiratory syndrome coronavirus2 ,3.9
515,6JSZ,D,58,IGHV3-74,T,['S' 'T'],"BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide",beta-secretase 2,A,homo sapiens,1.53
516,4ZFG,H,52,IGHV3-23,T,['S' 'Y'],Dual-specificity Fab 5A12 in complex with Angiopoietin 2,angiopoietin-2,A,homo sapiens,2.27
517,6UJ9,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens,2.9
518,6UJ9,H,52A,IGHV3-23,P,['G' 'S'],Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens,2.9
519,6UJ9,H,53,IGHV3-23,G,['S' 'G'],Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens,2.9
520,6UJ9,H,55,IGHV3-23,D,['G' 'S'],Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab,"hla class i histocompatibility antigen, b-7 alpha chain | isocitrate dehydrogenase [nadp], mitochondrial",A | C,homo sapiens | homo sapiens,2.9
521,6MJZ,H,31,IGHV4-59,S,['S' 'Y'],Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3,4.3
522,6MJZ,H,32,IGHV4-59,Y,['Y' 'W' 'H'],Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3,4.3
523,6MJZ,H,33,IGHV4-59,Y,['Y' 'S'],Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3,4.3
524,6MJZ,H,53,IGHV4-59,Y,['Y' 'T'],Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3,4.3
525,6MJZ,H,58,IGHV4-59,K,['N' 'Y'],Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174,fusion glycoprotein f0 | fusion glycoprotein f0 | fusion glycoprotein f0,C | A | B,human parainfluenza virus 3 | human parainfluenza virus 3 | human parainfluenza virus 3,4.3
526,6W4M,H,54,IGHV1-69,F,['F' 'L'],"CRYSTAL STRUCTURE OF THE ADCC-POTENT, WEAKLY NEUTRALIZING HIV ENV CO-RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1",clade a/e 93th057 hiv-1 gp120 core | m48u1 cd4 mimetic peptide,G | N,human immunodeficiency virus 1 | synthetic construct,3.2
527,5ERW,A,33,IGHV1-69,V,['A' 'T'],Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus,2.9
528,5ERW,A,50,IGHV1-69,G,['G' 'R'],Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus,2.9
529,5ERW,A,54,IGHV1-69,F,['F' 'L'],Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus,2.9
530,5ERW,A,56,IGHV1-69,T,['T' 'I'],Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus,2.9
531,5ERW,B,50,IGLV3-21,D,['Y' 'D'],Structure of HCV E2 glycoprotein antigenic Epitope II bound to the broadly neutralizing antibody HC84-26,hcv e2 glycoprotein epitope ii,C,hepatitis c virus,2.9
532,7M7B,H,53,IGHV4-34,H,['H' 'Y'],SARS-CoV-2 Spike:Fab 3D11 complex focused refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.95
533,7M7E,C,31,IGHV3-49,D,['D' 'Y'],6-Deoxyerythronolide B synthase (DEBS) hybrid module (M3/1) in complex with antibody fragment 1B2,"6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera  | 6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera ",A | B,saccharopolyspora erythraea | saccharopolyspora erythraea,3.2
534,7M7E,C,33,IGHV3-49,A,['A' 'P'],6-Deoxyerythronolide B synthase (DEBS) hybrid module (M3/1) in complex with antibody fragment 1B2,"6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera  | 6-deoxyerythronolide-b synthase erya2, modules 3 and 4,eryai,6-deoxyerythronolide-b synthase erya3, modules 5 and 6 chimera ",A | B,saccharopolyspora erythraea | saccharopolyspora erythraea,3.2
535,4XAW,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1,1.47
536,4XAW,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1,1.47
537,4XAW,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1,1.47
538,4XAW,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: Crystals cryoprotected with phosphatidic acid (08:0 PA),fragment of hiv glycoprotein (gp41) including the mperregion 671-683 ,P,human immunodeficiency virus 1,1.47
539,7THE,B,50,IGHV1-69,R,['G' 'R'],Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.79
540,7THE,B,54,IGHV1-69,F,['F' 'L'],Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.79
541,7THE,B,56,IGHV1-69,I,['T' 'I'],Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.79
542,7THE,B,73,IGHV1-69,K,['E' 'K'],Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.79
543,8DXT,H,52A,IGHV3-23,G,['G' 'S'],Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.25
544,8DXT,H,53,IGHV3-23,S,['S' 'G'],Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.25
545,8DXT,H,55,IGHV3-23,G,['G' 'S'],Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.25
546,8DXT,L,50,IGKV1-5,D,['D' 'K'],Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.,spike protein s1,R,severe acute respiratory syndrome coronavirus2 ,2.25
547,7YXU,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens,2.31
548,7YXU,H,52A,IGHV3-23,S,['G' 'S'],Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens,2.31
549,7YXU,H,53,IGHV3-23,G,['S' 'G'],Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB.,tumor necrosis factor receptor superfamily member 9,A,homo sapiens,2.31
550,2XQB,L,50,IGLV1-47,R,['R' 'S'],Crystal Structure of anti-IL-15 Antibody in Complex with human IL-15,interleukin 15,A,homo sapiens,2.6
551,5F9O,H,30,IGHV1-46,N,['T' 'N'],Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.09 in complex with HIV-1 clade A/E 93TH057 gp120,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,1.86
552,4HF5,H,31,IGHV3-33,S,['S' 'R'],Crystal structure of Fab 8F8 in complex a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus,3.004
553,3FN0,H,30,IGHV4-59,I,['S' 'Y'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
554,3FN0,H,31,IGHV4-59,N,['S' 'Y'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
555,3FN0,H,32,IGHV4-59,Y,['Y' 'W' 'H'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
556,3FN0,H,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
557,3FN0,H,50,IGHV4-59,H,['Y' 'R'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
558,3FN0,H,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
559,3FN0,H,58,IGHV4-59,K,['N' 'Y'],Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41,envelope polyprotein gp160,P,,1.8
560,6OZ9,H,27,IGHV4-4,A,['G' 'I'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
561,6OZ9,H,31,IGHV4-4,G,['S' 'N'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
562,6OZ9,H,32,IGHV4-4,Y,['S' 'W' 'Y'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
563,6OZ9,H,33,IGHV4-4,F,['N' 'W' 'Y'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
564,6OZ9,H,50,IGHV4-4,Y,['E' 'R' 'Y'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
565,6OZ9,H,53,IGHV4-4,S,['H' 'T'],Ebola virus glycoprotein in complex with EBOV-520 Fab,envelope glycoprotein | small secreted glycoprotein sgp,B | A,ebola virus | ebola virus,3.462
566,7RQQ,H,52,IGHV3-33,W,['W' 'S'],Structure of chimeric antibody F10heavy_L9light with PfCSP peptide NANPNVDP,pfcsp peptide nanpnvdp,P,plasmodium falciparum 3d7,1.89
567,7N3D,H,31,IGHV4-59,S,['S' 'Y'],Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.53
568,7N3D,H,33,IGHV4-59,Y,['Y' 'S'],Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.53
569,7N3D,H,50,IGHV4-59,Y,['Y' 'R'],Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.53
570,7N3D,H,58,IGHV4-59,K,['N' 'Y'],Crystal Structure of Human Fab S24-1564 in the complex with the N-teminal Domain of Nucleocapsid protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.53
571,5F96,H,30,IGHV1-46,N,['T' 'N'],Crystal structure of broadly neutralizing VH1-46 germline-derived CD4-binding site-directed antibody CH235.12 in complex with HIV-1 clade A/E 93TH057 gp120,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.2407
572,4KHT,H,33,IGHV1-69,A,['A' 'T'],Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1,2.8169999999999997
573,4KHT,H,50,IGHV1-69,S,['G' 'R'],Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1,2.8169999999999997
574,4KHT,H,54,IGHV1-69,F,['F' 'L'],Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1,2.8169999999999997
575,4KHT,H,56,IGHV1-69,T,['T' 'I'],Triple helix bundle of GP41 complexed with fab 8066,gp41 helix,A,human immunodeficiency virus 1,2.8169999999999997
576,4KHX,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1,2.9210000000000003
577,4KHX,H,50,IGHV1-69,S,['G' 'R'],Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1,2.9210000000000003
578,4KHX,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1,2.9210000000000003
579,4KHX,H,56,IGHV1-69,F,['T' 'I'],Crystal structure of gp41 helix complexed with antibody 8062,gp41 helix,A,human immunodeficiency virus 1,2.9210000000000003
580,4HFU,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus,3.106
581,4HFU,H,56,IGHV1-69,S,['T' 'I'],Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus,3.106
582,4HFU,H,73,IGHV1-69,E,['E' 'K'],Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin,hemagglutinin ha1,A,influenza a virus,3.106
583,7CR5,H,33,IGHV3-30,I,['A' 'G'],Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD,nucleoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.08
584,7CR5,H,50,IGHV3-30,V,['V' 'F'],Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD,nucleoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.08
585,7CR5,H,52,IGHV3-30,S,['S' 'R'],Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD,nucleoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.08
586,6VBO,L,27D,IGKV2-30,H,['Y' 'H'],Crystal structure of anti-HIV-1 antibody DH813 bound to gp120 V2 peptide,envelope glycoprotein gp160,C,human immunodeficiency virus 1,1.683
587,5WHK,H,50,IGHV3-23,S,['A' 'V'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
588,5WHK,H,52,IGHV3-23,G,['S' 'Y'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
589,5WHK,H,52A,IGHV3-23,S,['G' 'S'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
590,5WHK,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
591,5WHK,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
592,5WHK,L,51,IGLV2-23,D,['G' 'V'],Crystal structure of Fab fragment of antibody DX-2507 bound to FcRn-B2M,igg receptor fcrn large subunit p51 | beta-2-microglobulin,A | B,homo sapiens | homo sapiens,2.5
593,7DJZ,A,50,IGHV1-69,R,['G' 'R'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,2.397
594,7DJZ,A,54,IGHV1-69,L,['F' 'L'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,2.397
595,7DJZ,A,56,IGHV1-69,I,['T' 'I'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,2.397
596,7DJZ,A,73,IGHV1-69,K,['E' 'K'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,2.397
597,2NXZ,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.04
598,2NXZ,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.04
599,7UAQ,H,54,IGHV3-48,G,['S' 'G'],"Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement",spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.1
600,5DWU,H,52,IGHV3-23,R,['S' 'Y'],Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens,3.97
601,5DWU,H,52A,IGHV3-23,S,['G' 'S'],Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens,3.97
602,5DWU,H,53,IGHV3-23,S,['S' 'G'],Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens,3.97
603,5DWU,H,55,IGHV3-23,G,['G' 'S'],Beta common receptor in complex with a Fab,cytokine receptor common subunit beta | cytokine receptor common subunit beta,A | B,homo sapiens | homo sapiens,3.97
604,5XKU,C,33,IGHV4-31,G,['G' 'S'],Crystal structure of hemagglutinin globular head from an H7N9 influenza virus in complex with a neutralizing antibody HNIgGA6,influenza a virus,A,influenza a virus,1.78
605,6YWD,A,33,IGHV2-70,G,['G' 'E'],De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct,3.2
606,6YWD,A,58,IGHV2-70,H,['Y' 'F' 'H'],De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct,3.2
607,6YWD,B,50,IGKV1-5,D,['D' 'K'],De novo designed protein 4H_01 in complex with Mota antibody,de novo designed protein 4h_01,C,synthetic construct,3.2
608,6DC3,L,29,IGLV2-14,G,['G' 'S'],RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified ",3.501
609,6DC3,L,32,IGLV2-14,Y,['Y' 'L'],RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified ",3.501
610,6DC3,L,50,IGLV2-14,D,['E' 'D'],RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified ",3.501
611,6DC3,L,51,IGLV2-14,V,['V' 'G'],RSV prefusion F bound to RSD5 Fab,rsv fusion glycoprotein,F,"human respiratory syncytial virus a (straina2), human immunodeficiency virus 1, unidentified ",3.501
612,4PS4,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the complex between IL-13 and M1295 FAB,interleukin-13,A,homo sapiens,2.8
613,6XPY,B,26,IGHV4-4,G,['G' 'S'],Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus,3.603
614,6XPY,B,27,IGHV4-4,G,['G' 'I'],Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus,3.603
615,6XPY,B,31,IGHV4-4,I,['S' 'N'],Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus,3.603
616,6XPY,B,32,IGHV4-4,Y,['S' 'W' 'Y'],Human antibody S1V2-58 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus,3.603
617,6XPQ,B,2,IGHV4-61,V,['V' 'L'],Human antibody D1 H1-17/H3-14 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus (a/texas/50/2012(h3n2)),4.2
618,6XPQ,B,32,IGHV4-61,N,['G' 'S' 'Y'],Human antibody D1 H1-17/H3-14 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus (a/texas/50/2012(h3n2)),4.2
619,6XPQ,B,33,IGHV4-61,L,['S' 'Y' 'G'],Human antibody D1 H1-17/H3-14 in complex with the influenza hemagglutinin head domain of A/Texas/50/2012(H3N2),hemagglutinin,A,influenza a virus (a/texas/50/2012(h3n2)),4.2
620,4XC1,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
621,4XC1,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
622,4XC1,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
623,4XC1,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 GP41: crystals cryoprotected with sn-Glycerol 3-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
624,4XC3,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
625,4XC3,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
626,4XC3,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
627,4XC3,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41; crystals cryoprotected with rac-glycerol 1-phosphate,modified fragment of hiv-1 glycoprotein (gp41) includingthe mper region 671-683 ,P,human immunodeficiency virus 1,1.63
628,6IW0,H,26,IGHV4-59,G,['G' 'S'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
629,6IW0,H,27,IGHV4-59,G,['G' 'I'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
630,6IW0,H,29,IGHV4-59,T,['I' 'V' 'S'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
631,6IW0,H,30,IGHV4-59,Y,['S' 'Y'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
632,6IW0,H,31,IGHV4-59,N,['S' 'Y'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
633,6IW0,H,32,IGHV4-59,H,['Y' 'W' 'H'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
634,6IW0,H,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of 5A ScFv in complex with YFV-17D sE in postfusion state,envelope protein e,A,yellow fever virus (strain 17d vaccine),3.6
635,6U1N,L,30,IGKV1-13,S,['I' 'S'],GPCR-Beta arrestin structure in lipid bilayer,"beta-arrestin-1 | muscarinic acetylcholine receptor m2, vasopressin v2receptor chimera ",C | R,rattus norvegicus | homo sapiens,4
636,6U1N,L,32,IGKV1-13,A,['S' 'A'],GPCR-Beta arrestin structure in lipid bilayer,"beta-arrestin-1 | muscarinic acetylcholine receptor m2, vasopressin v2receptor chimera ",C | R,rattus norvegicus | homo sapiens,4
637,7OLY,H,28,IGHV4-39,S,['S' 'Y'],Structure of activin A in complex with an ActRIIB-Alk4 fusion reveal insight into activin receptor interactions,activin receptor type-2b,C,homo sapiens,3.265
638,7OLY,H,30,IGHV4-39,S,['S' 'G'],Structure of activin A in complex with an ActRIIB-Alk4 fusion reveal insight into activin receptor interactions,activin receptor type-2b,C,homo sapiens,3.265
639,7WLC,H,33,IGHV1-69,T,['A' 'T'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,4
640,7WLC,H,50,IGHV1-69,R,['G' 'R'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,4
641,7WLC,H,54,IGHV1-69,V,['F' 'L'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,4
642,7WLC,H,56,IGHV1-69,K,['T' 'I'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,4
643,7WLC,H,73,IGHV1-69,R,['E' 'K'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,4
644,7RU8,H,33,IGHV1-69,A,['A' 'T'],CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
645,7RU8,H,50,IGHV1-69,G,['G' 'R'],CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
646,7RU8,H,54,IGHV1-69,I,['F' 'L'],CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
647,7AZB,B,52,IGHV3-23,S,['S' 'Y'],Structure of DDR2 DS domain in complex with VHH,discoidin domain-containing receptor 2,A,homo sapiens,2.62
648,7AZB,B,60,IGHV3-23,A,['A' 'G'],Structure of DDR2 DS domain in complex with VHH,discoidin domain-containing receptor 2,A,homo sapiens,2.62
649,2XWT,B,50,IGLV1-51,D,['D' 'E'],Crystal structure of the TSH receptor in complex with a blocking type  TSHR autoantibody,thyrotropin receptor,C,homo sapiens,1.9
650,2NY7,H,52A,IGHV1-3,P,['A' 'T'],HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.3
651,2NY6,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.8
652,2NY6,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.8
653,2NY5,H,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.5
654,2NY5,H,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.5
655,2NY4,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
656,2NY4,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
657,2NY1,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,1.99
658,2NY1,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,1.99
659,2NY0,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.2
660,2NY0,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.2
661,6QB6,H,50,IGHV3-21,S,['S' 'Y'],Mcl1 in complex with a Fab,induced myeloid leukemia cell differentiation protein mcl-1 ,A,homo sapiens,2.24
662,6BCK,H,50,IGHV1-2,W,['R' 'W'],Crystal Structure of Broadly Neutralizing Antibody N49P7 in Complex with HIV-1 Clade AE strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.7
663,6BCK,H,61,IGHV1-2,W,['Q' 'H'],Crystal Structure of Broadly Neutralizing Antibody N49P7 in Complex with HIV-1 Clade AE strain 93TH057 gp120 core.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.7
664,6MF7,H,51,IGHV4-30-4,I,['I' 'F'],Structure of parvovirus B19 decorated with Fab molecules from a human antibody,vp2,A,human parvovirus b19,3.2
665,7DHA,C,52,IGHV3-23,S,['S' 'Y'],crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens,2.55
666,7DHA,C,52A,IGHV3-23,G,['G' 'S'],crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens,2.55
667,7DHA,C,53,IGHV3-23,S,['S' 'G'],crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens,2.55
668,7DHA,C,55,IGHV3-23,G,['G' 'S'],crystal structure of CD38 in complex with daratumumab,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens,2.55
669,7K8U,H,26,IGHV4-34,G,['G' 'F'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
670,7K8U,H,27,IGHV4-34,G,['G' 'S'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
671,7K8U,H,28,IGHV4-34,S,['S' 'T' 'G'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
672,7K8U,H,31,IGHV4-34,G,['G' 'W'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
673,7K8U,H,32,IGHV4-34,Y,['Y' 'S'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
674,7K8U,H,50,IGHV4-34,E,['E' 'Y'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
675,7K8U,H,52,IGHV4-34,N,['N' 'Y' 'I'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
676,7K8U,H,53,IGHV4-34,H,['H' 'Y'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)",spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.8
677,7K8Y,G,50,IGHV1-2,W,['R' 'W'],"Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)",spike glycoprotein | spike glycoprotein,B | D,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.4
678,7L3N,D,33,IGHV1-69,A,['A' 'T'],SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
679,7L3N,D,50,IGHV1-69,R,['G' 'R'],SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
680,7L3N,D,54,IGHV1-69,L,['F' 'L'],SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
681,7L3N,D,56,IGHV1-69,I,['T' 'I'],SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
682,7L3N,D,73,IGHV1-69,K,['E' 'K'],SARS-CoV 2 Spike Protein bound to LY-CoV555,spike glycoprotein | spike glycoprotein,B | C,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
683,6W00,H,31,IGHV3-33,N,['S' 'R'],Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,1.853
684,6W00,H,52,IGHV3-33,W,['W' 'S'],Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,1.853
685,4P59,H,50,IGHV3-23,A,['A' 'V'],HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.4
686,4P59,H,52,IGHV3-23,N,['S' 'Y'],HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.4
687,4P59,H,52A,IGHV3-23,S,['G' 'S'],HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.4
688,4P59,H,53,IGHV3-23,Q,['S' 'G'],HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.4
689,4P59,H,55,IGHV3-23,K,['G' 'S'],HER3 extracellular domain in complex with Fab fragment of MOR09825,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.4
690,7UCX,H,50,IGHV3-21,T,['S' 'Y'],LRP8 11H1 Fab complexed to a cyclized CR1 peptide,cyclized cr1 peptide,B,homo sapiens,1.72
691,7UCX,L,27D,IGKV2-30,Y,['Y' 'H'],LRP8 11H1 Fab complexed to a cyclized CR1 peptide,cyclized cr1 peptide,B,homo sapiens,1.72
692,1ADQ,L,50,IGLV3-21,D,['Y' 'D'],CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC,igg4 rea fc,A,homo sapiens,3.15
693,6XPX,B,33,IGHV3-30,V,['A' 'G'],Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2),hemagglutinin,A,influenza a virus,2.598
694,6XPX,B,50,IGHV3-30,V,['V' 'F'],Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2),hemagglutinin,A,influenza a virus,2.598
695,6XPX,B,52,IGHV3-30,S,['S' 'R'],Human antibody S1V2-51 in complex with the influenza hemagglutinin head domain of A/Aichi/2/1968 (X-31)(H3N2),hemagglutinin,A,influenza a virus,2.598
696,7YDY,H,33,IGHV1-69,A,['A' 'T'],SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.75
697,7YDY,H,54,IGHV1-69,L,['F' 'L'],SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.75
698,7YDY,H,56,IGHV1-69,I,['T' 'I'],SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.75
699,7YDY,H,73,IGHV1-69,K,['E' 'K'],SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.75
700,7YDY,L,69,IGLV1-40,T,['T' 'A'],SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,4.75
701,7YDI,H,33,IGHV1-69,A,['A' 'T'],"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.98
702,7YDI,H,54,IGHV1-69,L,['F' 'L'],"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.98
703,7YDI,H,56,IGHV1-69,I,['T' 'I'],"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.98
704,7YDI,L,69,IGLV1-40,T,['T' 'A'],"SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region",spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.98
705,6Q18,H,26,IGHV4-4,G,['G' 'S'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
706,6Q18,H,27,IGHV4-4,G,['G' 'I'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
707,6Q18,H,31,IGHV4-4,S,['S' 'N'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
708,6Q18,H,32,IGHV4-4,S,['S' 'W' 'Y'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
709,6Q18,H,33,IGHV4-4,N,['N' 'W' 'Y'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
710,6Q18,H,34,IGHV4-4,W,['W' 'S'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
711,6Q18,H,53,IGHV4-4,H,['H' 'T'],Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.55
712,6OCB,H,32,IGHV4-61,D,['G' 'S' 'Y'],Crystal structure of FluA-20 Fab in complex with the head domain of H3 (A/Hong Kong/1/1968),hemagglutinin,A,influenza a virus,2.1
713,6OCB,H,33,IGHV4-61,I,['S' 'Y' 'G'],Crystal structure of FluA-20 Fab in complex with the head domain of H3 (A/Hong Kong/1/1968),hemagglutinin,A,influenza a virus,2.1
714,6OCB,H,34,IGHV4-61,Y,['Y' 'W'],Crystal structure of FluA-20 Fab in complex with the head domain of H3 (A/Hong Kong/1/1968),hemagglutinin,A,influenza a virus,2.1
715,6VY6,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus,2.6
716,6VY6,H,52A,IGHV3-23,G,['G' 'S'],Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus,2.6
717,6VY6,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus,2.6
718,6VY6,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of Hendra receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,hendra henipavirus,2.6
719,6VY5,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus,3.4
720,6VY5,H,52A,IGHV3-23,G,['G' 'S'],Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus,3.4
721,6VY5,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus,3.4
722,6VY5,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of Nipah receptor binding protein head domain in complex with human neutralizing antibody HENV-26,receptor binding protein,A,nipah henipavirus,3.4
723,5GRJ,H,52,IGHV3-23,Y,['S' 'Y'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
724,5GRJ,H,52A,IGHV3-23,P,['G' 'S'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
725,5GRJ,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
726,5GRJ,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
727,5GRJ,L,32,IGLV2-14,Y,['Y' 'L'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
728,5GRJ,L,50,IGLV2-14,D,['E' 'D'],Crystal structure of human PD-L1 with monoclonal antibody avelumab,programmed cell death 1 ligand 1,A,homo sapiens,3.2060000000000004
729,1UJ3,B,30,IGHV1-46,K,['T' 'N'],Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor,tissue factor,C,homo sapiens,2.1
730,7XCP,H,31,IGHV3-13,S,['S' 'N'],Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab,spike protein s1,B,severe acute respiratory syndrome coronavirus2 ,0
731,7XCP,H,57,IGHV3-13,T,['T' 'P'],Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab,spike protein s1,B,severe acute respiratory syndrome coronavirus2 ,0
732,6GV4,H,52,IGHV3-23,S,['S' 'Y'],High-resolution Cryo-EM of Fab-labeled human parechovirus 3,vp1 | vp0,B | A,human parechovirus 3 | human parechovirus 3,2.8
733,6GV4,H,55,IGHV3-23,D,['G' 'S'],High-resolution Cryo-EM of Fab-labeled human parechovirus 3,vp1 | vp0,B | A,human parechovirus 3 | human parechovirus 3,2.8
734,5T33,H,31,IGHV3-33,E,['S' 'R'],"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus,3.2092
735,5T33,H,52,IGHV3-33,W,['W' 'S'],"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus,3.2092
736,5T33,L,50,IGLV3-10,E,['E' 'K'],"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus,3.2092
737,5T33,L,96,IGLV3-10,W,['T' 'A'],"Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.",rhpa gp120 core,G,human immunodeficiency virus,3.2092
738,5CZV,H,33,IGHV1-69,T,['A' 'T'],Crystal structure of Notch3 NRR in complex with 20350 Fab,neurogenic locus notch homolog protein 3,A,homo sapiens,3.19
739,5CZV,H,50,IGHV1-69,W,['G' 'R'],Crystal structure of Notch3 NRR in complex with 20350 Fab,neurogenic locus notch homolog protein 3,A,homo sapiens,3.19
740,5CZV,H,54,IGHV1-69,W,['F' 'L'],Crystal structure of Notch3 NRR in complex with 20350 Fab,neurogenic locus notch homolog protein 3,A,homo sapiens,3.19
741,5CZV,H,56,IGHV1-69,A,['T' 'I'],Crystal structure of Notch3 NRR in complex with 20350 Fab,neurogenic locus notch homolog protein 3,A,homo sapiens,3.19
742,2H32,H,42,IGHV5-51,G,['G' 'R'],Crystal structure of the pre-B cell receptor,immunoglobulin omega chain,B,homo sapiens,2.7
743,2F5B,H,54,IGHV2-5,D,['N' 'D'],CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE,protein (gp41 epitope),P,,2.0
744,7WH8,B,50,IGHV1-69,R,['G' 'R'],SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
745,7WH8,B,54,IGHV1-69,F,['F' 'L'],SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
746,7WH8,B,56,IGHV1-69,T,['T' 'I'],SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
747,7OH0,C,29,IGHV4-39,M,['I' 'W'],Tetanus neurotoxin HC domain in complex with TT104-Fab1,tetanus toxin,A,clostridium tetani,3.9
748,4FQY,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of broadly neutralizing antibody CR9114 bound to H3 influenza hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus,5.252999999999999
749,4FQY,H,73,IGHV1-69,I,['E' 'K'],Crystal structure of broadly neutralizing antibody CR9114 bound to H3 influenza hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus,5.252999999999999
750,4FQI,H,54,IGHV1-69,F,['F' 'L'],Crystal Structure of Fab CR9114 in Complex with a H5N1 influenza virus hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus,1.71
751,4FQI,H,56,IGHV1-69,S,['T' 'I'],Crystal Structure of Fab CR9114 in Complex with a H5N1 influenza virus hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus,1.71
752,4FQI,H,73,IGHV1-69,I,['E' 'K'],Crystal Structure of Fab CR9114 in Complex with a H5N1 influenza virus hemagglutinin,hemagglutinin ha2 | hemagglutinin ha1,B | A,influenza a virus | influenza a virus,1.71
753,6UYF,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.06
754,6UYF,H,56,IGHV1-69,V,['T' 'I'],Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B,envelope glycoprotein e2,E,recombinant hepatitis c virus hk6a/jfh-1,2.06
755,5TE6,H,50,IGHV1-2,W,['R' 'W'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.4
756,5TE6,H,61,IGHV1-2,G,['Q' 'H'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.4
757,5TE6,L,32,IGKV1-13,D,['S' 'A'],Crystal Structure of Broadly Neutralizing VRC01-class Antibody N6 in Complex with HIV-1 Clade AE Strain 93TH057 gp120 Core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.4
758,7STR,H,31,IGHV4-59,S,['S' 'Y'],Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.5
759,7STR,H,33,IGHV4-59,Y,['Y' 'S'],Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.5
760,7STR,H,50,IGHV4-59,Y,['Y' 'R'],Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.5
761,7STR,H,53,IGHV4-59,Y,['Y' 'T'],Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.5
762,7STR,H,58,IGHV4-59,K,['N' 'Y'],Crystal Structure of Human Fab S24-1063 in the Complex with the N-teminal Domain of Nucleocapsid Protein from SARS CoV-2,nucleoprotein,C,severe acute respiratory syndrome coronavirus2 ,1.5
763,2NY2,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
764,2NY2,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
765,5U3J,H,52C,IGHV3-15,K,['T' 'A'],Crystal Structure of DH511.1 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,2.74
766,5U3J,H,53,IGHV3-15,D,['D' 'N'],Crystal Structure of DH511.1 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,2.74
767,5U3O,H,52,IGHV3-15,R,['K' 'E'],Crystal Structure of DH511.2_K3 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,1.761
768,5U3O,H,52C,IGHV3-15,K,['T' 'A'],Crystal Structure of DH511.2_K3 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,1.761
769,5U3O,H,53,IGHV3-15,D,['D' 'N'],Crystal Structure of DH511.2_K3 Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,1.761
770,5U3N,H,53,IGHV3-15,D,['D' 'N'],Crystal Structure of DH511.12P Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,2.0
771,5U3M,H,53,IGHV3-15,D,['D' 'N'],Crystal Structure of DH511.11P Fab in Complex with HIV-1 gp41 MPER Peptide,gp41 mper peptide,A,human immunodeficiency virus 1,2.418
772,4UV7,H,50,IGHV3-23,G,['A' 'V'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
773,4UV7,H,52,IGHV3-23,L,['S' 'Y'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
774,4UV7,H,52A,IGHV3-23,G,['G' 'S'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
775,4UV7,H,53,IGHV3-23,G,['S' 'G'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
776,4UV7,H,55,IGHV3-23,E,['G' 'S'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
777,4UV7,L,27D,IGKV2-30,H,['Y' 'H'],The complex structure of extracellular domain of EGFR and GC1118A,epidermal growth factor receptor,A,homo sapiens,2.1
778,5I8C,A,50,IGHV1-2,W,['R' 'W'],Crystal Structure of HIV-1 Clade A BG505 Fusion Peptide (residue 512-520) in Complex with Broadly Neutralizing Antibody VRC34.01 Fab,hiv-1 clade a bg505 fusion peptide (residue 512-520),C,human immunodeficiency virus 1,1.54
779,5WT9,H,31,IGHV3-33,N,['S' 'R'],Complex structure of PD-1 and nivolumab-Fab,programmed cell death protein 1,G,homo sapiens,2.401
780,5WT9,H,52,IGHV3-33,W,['W' 'S'],Complex structure of PD-1 and nivolumab-Fab,programmed cell death protein 1,G,homo sapiens,2.401
781,2NY3,D,54,IGHV1-69,L,['F' 'L'],"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
782,2NY3,D,56,IGHV1-69,V,['T' 'I'],"HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b",envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
783,3K2U,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of HGFA in complex with the allosteric inhibitory antibody Fab40,hepatocyte growth factor activator long chain,A,homo sapiens,2.35
784,7E23,B,23,IGHV4-34,A,['A' 'G'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
785,7E23,B,24,IGHV4-34,V,['V' 'G'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
786,7E23,B,25,IGHV4-34,Y,['Y' 'S'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
787,7E23,B,26,IGHV4-34,G,['G' 'F'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
788,7E23,B,29,IGHV4-34,F,['F' 'V' 'Y'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
789,7E23,B,30,IGHV4-34,S,['S' 'Y'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
790,7E23,B,32,IGHV4-34,Y,['Y' 'S'],SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.3
791,7ZBU,H,33,IGHV3-30,G,['A' 'G'],CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
792,7ZBU,H,50,IGHV3-30,V,['V' 'F'],CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
793,7ZBU,H,52,IGHV3-30,S,['S' 'R'],CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
794,4WY7,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b ,2.1
795,4WY7,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b ,2.1
796,4WY7,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b ,2.1
797,4WY7,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of recombinant 4E10 expressed in Escherichia coli with epitope bound,envelope glycoprotein gp160,P,human immunodeficiency virus type 1 group msubtype b ,2.1
798,5XXY,H,50,IGHV3-23,W,['A' 'V'],Complex structure of PD-L1 with atezolizumab Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.9
799,5XXY,H,52,IGHV3-23,S,['S' 'Y'],Complex structure of PD-L1 with atezolizumab Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.9
800,5XXY,H,52A,IGHV3-23,P,['G' 'S'],Complex structure of PD-L1 with atezolizumab Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.9
801,5XXY,H,53,IGHV3-23,Y,['S' 'G'],Complex structure of PD-L1 with atezolizumab Fab,programmed cell death 1 ligand 1,A,homo sapiens,2.9
802,5OCC,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens,2.5
803,5OCC,H,52A,IGHV3-23,G,['G' 'S'],Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens,2.5
804,5OCC,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens,2.5
805,5OCC,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of CD32b (Fc Gamma Receptor IIb) in complex with Human IgG1 Fab fragment (6G08),low affinity immunoglobulin gamma fc region receptor ii-b,A,homo sapiens,2.5
806,5VKD,H,54,IGHV3-66,S,['G' 'C'],Crystal structure of C-terminal domain of Ebola (Bundibugyo) nucleoprotein in complex with Fab fragment,nucleoprotein,A,bundibugyo ebolavirus,1.749
807,7F9W,B,33,IGHV1-69,A,['A' 'T'],CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens,3.2
808,7F9W,B,50,IGHV1-69,R,['G' 'R'],CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens,3.2
809,7F9W,B,54,IGHV1-69,F,['F' 'L'],CD25 in complex with Fab,interleukin-2 receptor subunit alpha,A,homo sapiens,3.2
810,7LO8,H,52,IGHV3-23,S,['S' 'Y'],NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus,3.16
811,7LO8,H,53,IGHV3-23,S,['S' 'G'],NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus,3.16
812,7LO8,L,90,IGKV1-39,Q,['Q' 'C'],NorA in complex with Fab36,quinolone resistance protein nora,Z,staphylococcus aureus,3.16
813,4PY8,I,26,IGHV3-30,E,['G' 'A'],Crystal structure of Fab 3.1 in complex with the 1918 influenza virus hemagglutinin,hemagglutinin ha2 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus,2.91
814,4PY8,I,94,IGHV3-30,R,['R' 'K'],Crystal structure of Fab 3.1 in complex with the 1918 influenza virus hemagglutinin,hemagglutinin ha2 chain | hemagglutinin ha1 chain,B | A,influenza a virus | influenza a virus,2.91
815,4R4F,H,31,IGHV4-34,G,['G' 'W'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,3.514
816,4R4F,H,32,IGHV4-34,H,['Y' 'S'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,3.514
817,4R4F,H,50,IGHV4-34,E,['E' 'Y'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,3.514
818,4R4F,H,52,IGHV4-34,K,['N' 'Y' 'I'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,3.514
819,4R4F,H,59,IGHV4-34,Y,['Y' 'N'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 YU2 gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,3.514
820,6VUG,D,31,IGHV3-33,T,['S' 'R'],Diabody bound to a Reverse Transcriptase Aptamer Complex,reverse transcriptase p51,B,human immunodeficiency virus 1,3.0
821,6VUG,D,52,IGHV3-33,W,['W' 'S'],Diabody bound to a Reverse Transcriptase Aptamer Complex,reverse transcriptase p51,B,human immunodeficiency virus 1,3.0
822,7OW1,H,31,IGHV3-33,S,['S' 'R'],Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,1.4
823,7OW1,H,35,IGHV3-33,H,['H' 'Y'],Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,1.4
824,7OW1,H,52,IGHV3-33,W,['W' 'S'],Crystal Structure of TAP01 in complex with amyloid beta peptide,amyloid-beta precursor protein,A,homo sapiens,1.4
825,5GHW,H,50,IGHV3-15,R,['R' 'C'],Crystal structure of broad neutralizing antibody 10E8 with long epitope bound,endogenous retrovirus group k member 8 env polyprotein,P,human immunodeficiency virus 1,2.4
826,5GHW,H,52,IGHV3-15,T,['K' 'E'],Crystal structure of broad neutralizing antibody 10E8 with long epitope bound,endogenous retrovirus group k member 8 env polyprotein,P,human immunodeficiency virus 1,2.4
827,5GHW,H,52C,IGHV3-15,G,['T' 'A'],Crystal structure of broad neutralizing antibody 10E8 with long epitope bound,endogenous retrovirus group k member 8 env polyprotein,P,human immunodeficiency virus 1,2.4
828,5GHW,H,53,IGHV3-15,E,['D' 'N'],Crystal structure of broad neutralizing antibody 10E8 with long epitope bound,endogenous retrovirus group k member 8 env polyprotein,P,human immunodeficiency virus 1,2.4
829,1GC1,H,54,IGHV1-69,L,['F' 'L'],HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY,envelope protein gp120,G,human immunodeficiency virus 1,2.5
830,1GC1,H,56,IGHV1-69,V,['T' 'I'],HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY,envelope protein gp120,G,human immunodeficiency virus 1,2.5
831,5W2B,H,54,IGHV3-66,S,['G' 'C'],Crystal structure of C-terminal domain of Ebola (Reston) nucleoprotein in complex with Fab fragment,nucleoprotein,A,reston ebolavirus,2.25
832,5D70,H,52,IGHV3-23,S,['S' 'Y'],"Crystal structure of MOR03929, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens,2.06
833,5D70,H,52A,IGHV3-23,Y,['G' 'S'],"Crystal structure of MOR03929, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens,2.06
834,5D71,H,52,IGHV3-23,S,['S' 'Y'],"Crystal structure of MOR04302, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens,2.25
835,5D71,H,52A,IGHV3-23,Y,['G' 'S'],"Crystal structure of MOR04302, a neutralizing anti-human GM-CSF antibody Fab fragment in complex with human GM-CSF",granulocyte-macrophage colony-stimulating factor,A,homo sapiens,2.25
836,3B2V,H,32,IGHV4-30-4,G,['G' 'Y'],Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens,3.3
837,3B2V,H,33,IGHV4-30-4,D,['D' 'Y' 'G'],Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens,3.3
838,3B2V,H,35,IGHV4-30-4,Y,['Y' 'S'],Crystal structure of the extracellular region of the epidermal growth factor receptor in complex with the Fab fragment of IMC-11F8,epidermal growth factor receptor,A,homo sapiens,3.3
839,7L5B,H,50,IGHV1-2,W,['R' 'W'],Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD).,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.18
840,7X92,H,31,IGHV3-33,N,['S' 'R'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
841,7X92,H,52,IGHV3-33,W,['W' 'S'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
842,7ND8,H,56,IGHV3-11,T,['T' 'Y'],EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.5
843,7ND8,H,58,IGHV3-11,Y,['Y' 'N'],EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.5
844,7ND0,H,50,IGHV3-21,Y,['S' 'Y'],lateral-open conformation of the wild-type BAM complex (BamABCDE) bound to a bactericidal Fab fragment,outer membrane protein assembly factor bama,A,escherichia coli k-12,5.2
845,5VIC,H,53,IGHV3-23,I,['S' 'G'],Crystal structure of anti-Zika antibody Z004 bound to DENV-1 Envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus type 1 (strain nauru/westpac/1974) ,3.0
846,5VIC,L,50,IGKV1-5,T,['D' 'K'],Crystal structure of anti-Zika antibody Z004 bound to DENV-1 Envelope protein DIII,dengue 1 envelope diii domain,E,dengue virus type 1 (strain nauru/westpac/1974) ,3.0
847,7WSL,H,50,IGHV3-23,T,['A' 'V'],PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens,1.534
848,7WSL,H,52,IGHV3-23,S,['S' 'Y'],PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens,1.534
849,7WSL,H,52A,IGHV3-23,G,['G' 'S'],PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens,1.534
850,7WSL,H,53,IGHV3-23,G,['S' 'G'],PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens,1.534
851,7WSL,H,55,IGHV3-23,S,['G' 'S'],PD-1 in complex with Dostarlimab,programmed cell death protein 1,D,homo sapiens,1.534
852,8DM0,H,50,IGHV3-30,N,['V' 'F'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
853,8DM0,H,52,IGHV3-30,Y,['S' 'R'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
854,8DM0,H,60,IGHV3-30,N,['A' 'T'],Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
855,5GJS,H,31,IGHV4-4,S,['S' 'N'],Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.9
856,5GJS,H,32,IGHV4-4,Y,['S' 'W' 'Y'],Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.9
857,5GJS,H,33,IGHV4-4,Y,['N' 'W' 'Y'],Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.9
858,5GJS,H,50,IGHV4-4,R,['E' 'R' 'Y'],Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.9
859,5GJS,L,50,IGKV1-5,K,['D' 'K'],Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.9
860,5GJT,H,31,IGHV4-4,S,['S' 'N'],Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,3.1
861,5GJT,H,32,IGHV4-4,Y,['S' 'W' 'Y'],Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,3.1
862,5GJT,H,33,IGHV4-4,Y,['N' 'W' 'Y'],Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,3.1
863,5GJT,H,50,IGHV4-4,R,['E' 'R' 'Y'],Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,3.1
864,5GJT,L,50,IGKV1-5,K,['D' 'K'],Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,3.1
865,6U6U,H,50,IGHV1-2,E,['R' 'W'],IL36R extracellular domain in complex with BI655130 Fab,interleukin-1 receptor-like 2,R,homo sapiens,2.31
866,2R0K,H,94,IGHV3-64,R,['R' 'K'],Protease domain of HGFA with inhibitor Fab58,hepatocyte growth factor activator,A,homo sapiens,3.51
867,7X26,H,33,IGHV1-69,G,['A' 'T'],S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 ,3.685
868,7X26,H,50,IGHV1-69,R,['G' 'R'],S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 ,3.685
869,7X26,H,54,IGHV1-69,L,['F' 'L'],S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 ,3.685
870,7X26,H,56,IGHV1-69,I,['T' 'I'],S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 ,3.685
871,7X26,H,73,IGHV1-69,K,['E' 'K'],S41 neutralizing antibody Fab(MERS-CoV),spike glycoprotein,I,severe acute respiratory syndrome coronavirus2 ,3.685
872,6BKD,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,3.25
873,6BKD,H,56,IGHV1-69,T,['T' 'I'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,3.25
874,4R4H,H,31,IGHV4-34,G,['G' 'W'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,4.28
875,4R4H,H,50,IGHV4-34,E,['E' 'Y'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,4.28
876,4R4H,H,52,IGHV4-34,K,['N' 'Y' 'I'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,4.28
877,4R4H,H,53,IGHV4-34,H,['H' 'Y'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,4.28
878,4R4H,H,59,IGHV4-34,Y,['Y' 'N'],"Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120",hiv-1 env gp120,A,human immunodeficiency virus 1,4.28
879,7S0E,H,52,IGHV3-23,S,['S' 'Y'],Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4.9
880,6BKC,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,2.6
881,6BKC,H,56,IGHV1-69,V,['T' 'I'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,2.6
882,6BKB,H,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,2.799
883,6BKB,H,56,IGHV1-69,T,['T' 'I'],Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A,polyprotein,E,recombinant hepatitis c virus hk6a/jfh-1,2.799
884,3W9E,A,54,IGHV1-69,F,['F' 'L'],Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD,envelope glycoprotein d,C,human herpesvirus 2,2.3
885,3W9E,A,56,IGHV1-69,K,['T' 'I'],Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD,envelope glycoprotein d,C,human herpesvirus 2,2.3
886,3W9E,A,73,IGHV1-69,K,['E' 'K'],Structure of Human Monoclonal Antibody E317 Fab Complex with HSV-2 gD,envelope glycoprotein d,C,human herpesvirus 2,2.3
887,7X2A,H,33,IGHV1-69,G,['A' 'T'],MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus ,2.49
888,7X2A,H,50,IGHV1-69,R,['G' 'R'],MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus ,2.49
889,7X2A,H,54,IGHV1-69,L,['F' 'L'],MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus ,2.49
890,7X2A,H,56,IGHV1-69,I,['T' 'I'],MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus ,2.49
891,7X2A,H,73,IGHV1-69,K,['E' 'K'],MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab),mers-cov spike glycoprotein,A,middle east respiratory syndrome-relatedcoronavirus ,2.49
892,3GBN,H,54,IGHV1-69,F,['F' 'L'],Crystal Structure of Fab CR6261 in Complex with the 1918 H1N1 influenza virus hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/brevigmission/1/1918(h1n1))  | influenza a virus (a/brevigmission/1/1918(h1n1)) ,2.2
893,3GBN,H,56,IGHV1-69,T,['T' 'I'],Crystal Structure of Fab CR6261 in Complex with the 1918 H1N1 influenza virus hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/brevigmission/1/1918(h1n1))  | influenza a virus (a/brevigmission/1/1918(h1n1)) ,2.2
894,3GBN,H,73,IGHV1-69,D,['E' 'K'],Crystal Structure of Fab CR6261 in Complex with the 1918 H1N1 influenza virus hemagglutinin,hemagglutinin | hemagglutinin,B | A,influenza a virus (a/brevigmission/1/1918(h1n1))  | influenza a virus (a/brevigmission/1/1918(h1n1)) ,2.2
895,3IDX,H,33,IGHV3-30,A,['A' 'G'],"Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222",hiv-1 hxbc2 gp120 core,G,human immunodeficiency virus 1,2.5
896,3IDX,H,52,IGHV3-30,K,['S' 'R'],"Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222",hiv-1 hxbc2 gp120 core,G,human immunodeficiency virus 1,2.5
897,6Y97,H,33,IGHV1-69,W,['A' 'T'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.33
898,6Y97,H,50,IGHV1-69,R,['G' 'R'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.33
899,6Y97,H,54,IGHV1-69,D,['F' 'L'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.33
900,6Y97,H,56,IGHV1-69,D,['T' 'I'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.33
901,6Y97,H,73,IGHV1-69,K,['E' 'K'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.33
902,5CJQ,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of a trimeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114,"designed influenza hemagglutinin stem #4900, ha2 | designed influenza hemagglutinin stem #4900, ha1",B | A,synthetic construct | synthetic construct,3.6
903,5CJQ,H,56,IGHV1-69,S,['T' 'I'],Crystal structure of a trimeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114,"designed influenza hemagglutinin stem #4900, ha2 | designed influenza hemagglutinin stem #4900, ha1",B | A,synthetic construct | synthetic construct,3.6
904,5CJQ,H,73,IGHV1-69,I,['E' 'K'],Crystal structure of a trimeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114,"designed influenza hemagglutinin stem #4900, ha2 | designed influenza hemagglutinin stem #4900, ha1",B | A,synthetic construct | synthetic construct,3.6
905,7NFR,B,50,IGHV3-23,S,['A' 'V'],Fujian capmidlink domain in complex with Nb8194,polymerase basic protein 2,A,influenza a virus (a/duck/fujian/13/2002(h5n1)) ,1.88
906,6Y9A,H,33,IGHV1-69,W,['A' 'T'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.2
907,6Y9A,H,50,IGHV1-69,R,['G' 'R'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.2
908,6Y9A,H,54,IGHV1-69,D,['F' 'L'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.2
909,6Y9A,H,56,IGHV1-69,D,['T' 'I'],Structure of full-length CD20 in complex with Obinutuzumab Fab,b-lymphocyte antigen cd20 | b-lymphocyte antigen cd20,A | B,homo sapiens | homo sapiens,4.2
910,5VOB,H,50,IGHV3-30,F,['V' 'F'],Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508),3.02
911,5VOB,H,52,IGHV3-30,S,['S' 'R'],Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508),3.02
912,5VOC,H,50,IGHV3-30,F,['V' 'F'],Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508),3.99
913,5VOC,H,52,IGHV3-30,S,['S' 'R'],Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD,envelope glycoprotein ul130 | envelope glycoprotein l,D | B,human cytomegalovirus (strain merlin) | human cytomegalovirus (strain 5508),3.99
914,5VOD,L,27D,IGKV2-30,Y,['Y' 'H'],Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6,envelope glycoprotein ul128 | envelope glycoprotein ul131a,C | E,human cytomegalovirus (strain ad169) | human cytomegalovirus (strain merlin),5.9
915,7TPJ,H,94,IGHV3-64,R,['R' 'K'],Single-Particle Cryo-EM Structure of the WaaL O-antigen ligase in its apo state,putative cell surface polysaccharide polymerase/ligase,B,cupriavidus metallidurans,3.46
916,7ENF,P,52,IGHV3-30,S,['S' 'R'],Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30,spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,2.76
917,7ENG,H,52,IGHV3-30,S,['S' 'R'],Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30),spike glycoprotein,B,severe acute respiratory syndrome coronavirus2 ,3.59
918,7TPG,H,94,IGHV3-64,R,['R' 'K'],Single-Particle Cryo-EM Structure of the WaaL O-antigen ligase in its ligand bound state,putative cell surface polysaccharide polymerase/ligase,B,cupriavidus metallidurans,3.23
919,7X90,E,33,IGHV3-30,P,['A' 'G'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326,spike glycoprotein,G,severe acute respiratory syndrome coronavirus2 ,0
920,7X90,E,50,IGHV3-30,V,['V' 'F'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326,spike glycoprotein,G,severe acute respiratory syndrome coronavirus2 ,0
921,7X90,E,52,IGHV3-30,S,['S' 'R'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326,spike glycoprotein,G,severe acute respiratory syndrome coronavirus2 ,0
922,3IDI,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide ALDKWNQ,gp41 mper peptide,C,,2.1
923,3IDJ,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide analog ELD(Orn)WAS,gp41 mper peptide analog,C,,2.24
924,3IDN,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 Fab' fragment in complex with gp41 Peptide analog ELD(Paf)WAS,gp41 mper peptide analog,C,,2.25
925,1IKF,H,58,IGHV3-11,F,['Y' 'N'],A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX,cyclosporin a,C,tolypocladium inflatum,2.5
926,4O58,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of broadly neutralizing antibody F045-092 in complex with A/Victoria/3/1975 (H3N2) influenza hemagglutinin,hemagglutinin ha1 chain,A,influenza a virus,2.7501
927,4O58,H,73,IGHV1-69,G,['E' 'K'],Crystal structure of broadly neutralizing antibody F045-092 in complex with A/Victoria/3/1975 (H3N2) influenza hemagglutinin,hemagglutinin ha1 chain,A,influenza a virus,2.7501
928,1G9N,H,54,IGHV1-69,L,['F' 'L'],HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.9
929,1G9N,H,56,IGHV1-69,V,['T' 'I'],HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.9
930,6O39,B,52,IGHV3-23,Y,['S' 'Y'],Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens,1.8
931,6O39,B,52A,IGHV3-23,S,['G' 'S'],Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens,1.8
932,6O39,B,53,IGHV3-23,S,['S' 'G'],Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens,1.8
933,6O39,B,55,IGHV3-23,G,['G' 'S'],Crystal structure of Frizzled 5 CRD in complex with F2.I Fab,frizzled-5,C,homo sapiens,1.8
934,6W05,H,31,IGHV3-33,N,['S' 'R'],Crystal structure of Fab356 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,2.516
935,6W05,H,52,IGHV3-33,W,['W' 'S'],Crystal structure of Fab356 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,2.516
936,7S6L,H,50,IGHV1-69,R,['G' 'R'],J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4
937,7S6L,H,54,IGHV1-69,L,['F' 'L'],J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4
938,7S6L,H,56,IGHV1-69,R,['T' 'I'],J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,4
939,5UG0,D,31,IGHV3-13,I,['S' 'N'],Human antibody H2897 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006,hemagglutinin ha1,A,influenza a virus (a/solomonislands/3/2006(h1n1)) ,3.4
940,7VUI,N,33,IGHV3-48,K,['S' 'E'],Cryo-EM structure of a class A orphan GPCR,isoform gnas-2 of guanine nucleotide-binding protein g(s)subunit alpha isoforms short  | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,3.3
941,7VUJ,N,33,IGHV3-48,K,['S' 'E'],Cryo-EM structure of a class A orphan GPCR,isoform gnas-2 of guanine nucleotide-binding protein g(s)subunit alpha isoforms short  | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,3.8
942,7CM4,H,33,IGHV2-70,G,['G' 'E'],Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.71
943,7CM4,H,58,IGHV2-70,Y,['Y' 'F' 'H'],Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.71
944,7CM4,H,64,IGHV2-70,K,['K' 'N'],Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.71
945,7CM4,H,94,IGHV2-70,R,['R' 'H'],Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.71
946,7CM4,L,50,IGLV1-51,D,['D' 'E'],Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.71
947,7VUX,H,50,IGHV3-23,T,['A' 'V'],Complex structure of PD1 and 609A-Fab,programmed cell death protein 1,A,homo sapiens,1.64
948,7VUX,H,52,IGHV3-23,S,['S' 'Y'],Complex structure of PD1 and 609A-Fab,programmed cell death protein 1,A,homo sapiens,1.64
949,7LCV,A,52,IGHV3-23,S,['S' 'Y'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,1.7
950,7LCV,A,53,IGHV3-23,S,['S' 'G'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,1.7
951,7LCV,A,55,IGHV3-23,G,['G' 'S'],Factor H enhancing human antibody fragment (Fab) to meningococcal Factor H binding protein,factor h binding protein,C,neisseria meningitidis,1.7
952,6OKM,H,30,IGHV1-46,T,['T' 'N'],Human OX40R (TNFRSF4) bound to Fab 3C8,tumor necrosis factor receptor superfamily member 4,R,homo sapiens,2.1
953,2P8L,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN,gp41 peptide,C,,2.44
954,2P8M,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN in new crystal form,gp41 peptide,C,,2.7
955,6O3A,B,50,IGHV3-21,Y,['S' 'Y'],Crystal structure of Frizzled 7 CRD in complex with F7.B Fab,frizzled-7,E,homo sapiens,2.1
956,2P8P,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LELDKWASLW[N-Ac],gp41 peptide,C,,2.7
957,5O4G,B,30,IGHV1-46,T,['T' 'N'],HER2 in complex with Fab MF3958,receptor tyrosine-protein kinase erbb-2,C,homo sapiens,3.0
958,7EPU,A,50,IGLV3-21,D,['Y' 'D'],Crystal structure of HsALC1,chromodomain-helicase-dna-binding protein 1-like,B,homo sapiens,3.5
959,6D0X,A,31,IGHV3-33,S,['S' 'R'],Crystal structure of chimeric H.2140 / K.1210 Fab in complex with circumsporozoite protein NANP3,nanp3,C,plasmodium falciparum,1.849
960,6D0X,A,52,IGHV3-33,W,['W' 'S'],Crystal structure of chimeric H.2140 / K.1210 Fab in complex with circumsporozoite protein NANP3,nanp3,C,plasmodium falciparum,1.849
961,7U8L,H,53,IGHV3-23,N,['S' 'G'],Crystal structure of chimeric hemagglutinin cH15/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus,4.56
962,7U8L,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of chimeric hemagglutinin cH15/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus,4.56
963,7U8J,H,53,IGHV3-23,N,['S' 'G'],Crystal structure of chimeric hemagglutinin cH4/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus,4.9
964,7U8J,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of chimeric hemagglutinin cH4/3 in complex with broad protective antibody 31.a.83,hemagglutinin ha2 subunit | hemagglutinin ha1 subunit,B | A,influenza a virus | influenza a virus,4.9
965,2DD8,H,33,IGHV1-69,T,['A' 'T'],Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus,2.3
966,2DD8,H,50,IGHV1-69,G,['G' 'R'],Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus,2.3
967,2DD8,H,54,IGHV1-69,L,['F' 'L'],Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus,2.3
968,2DD8,H,56,IGHV1-69,I,['T' 'I'],Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody,spike glycoprotein,S,sars coronavirus,2.3
969,6NN3,H,66,IGHV4-31,R,['L' 'R'],Structure of parvovirus B19 decorated with Fab molecules from a human antibody,vp2 of b19 parvovirus,A,human parvovirus b19,3.22
970,7E8M,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,2.09
971,8DI5,H,50,IGHV3-23,N,['A' 'V'],Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
972,8DI5,H,52,IGHV3-23,Y,['S' 'Y'],Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
973,8DI5,H,53,IGHV3-23,Y,['S' 'G'],Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
974,8DI5,H,60,IGHV3-23,N,['A' 'G'],Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6),spike glycoprotein,C,severe acute respiratory syndrome coronavirus2 ,0
975,7XW7,B,50,IGLV1-51,D,['D' 'E'],TSHR-K1-70 complex,thyrotropin receptor,R,homo sapiens,0
976,3EGS,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 scrambledFP-MPER scrHyb3K construct GIGAFGLLGFLAAGSKK-Ahx-K656NEQELLELDKWASLWN671 soaked in ammonium sulfate,gp41 scrfp-mper construct,C,,3.6
977,5UEM,H,30,IGHV1-46,P,['T' 'N'],Crystal structure of 354NC37 Fab in complex with HIV-1 clade AE strain 93TH057 gp120,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.7
978,5UEK,L,29,IGKV1-13,V,['G' 'I'],Structure of antigen-Fab 12E complex with Histone chaperone ASF1,histone chaperone asf1,A,saccharomyces cerevisiae,1.7
979,5UEK,L,30,IGKV1-13,S,['I' 'S'],Structure of antigen-Fab 12E complex with Histone chaperone ASF1,histone chaperone asf1,A,saccharomyces cerevisiae,1.7
980,5UEK,L,32,IGKV1-13,A,['S' 'A'],Structure of antigen-Fab 12E complex with Histone chaperone ASF1,histone chaperone asf1,A,saccharomyces cerevisiae,1.7
981,4XWG,H,52,IGHV3-33,W,['W' 'S'],Crystal Structure of LCAT (C31Y) in complex with Fab1,phosphatidylcholine-sterol acyltransferase,A,homo sapiens,2.65
982,6APB,H,33,IGHV2-70,G,['G' 'E'],Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus,3.0
983,6APB,H,50,IGHV2-70,R,['L' 'R'],Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus,3.0
984,6APB,H,58,IGHV2-70,Y,['Y' 'F' 'H'],Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein,"fusion glycoprotein f0,fusion glycoprotein f0 | fusion glycoprotein f0,fusion glycoprotein f0",C | A,human respiratory syncytial virus | human respiratory syncytial virus,3.0
985,5W42,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2),hemagglutinin,A,influenza a virus(a/swine/minnesota/a01134337/2010(h3n2)) ,3.569
986,5W42,H,56,IGHV1-69,S,['T' 'I'],Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2),hemagglutinin,A,influenza a virus(a/swine/minnesota/a01134337/2010(h3n2)) ,3.569
987,2VH5,H,33,IGHV3-48,S,['S' 'E'],CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (disulfide free mutant)  COMPLEX,gtpase hras,R,homo sapiens,2.7
988,3Q1S,H,30,IGHV4-59,I,['S' 'Y'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
989,3Q1S,H,31,IGHV4-59,N,['S' 'Y'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
990,3Q1S,H,32,IGHV4-59,Y,['Y' 'W' 'H'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
991,3Q1S,H,33,IGHV4-59,Y,['Y' 'S'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
992,3Q1S,H,50,IGHV4-59,H,['Y' 'R'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
993,3Q1S,H,53,IGHV4-59,Y,['Y' 'T'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
994,3Q1S,H,58,IGHV4-59,K,['N' 'Y'],HIV-1 neutralizing antibody Z13e1 in complex with epitope display protein,interleukin-22,I,homo sapiens,2.15
995,6U38,L,69,IGKV3-11,T,['T' 'R'],PCSK9 in complex with a Fab and compound 8,proprotein convertase subtilisin/kexin type 9,B,homo sapiens,2.73
996,7JV2,L,76,IGLV7-46,S,['S' 'L'],SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains),sars-cov-2 spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.5
997,7TTY,H,1,IGHV4-39,Q,['Q' 'R'],Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1,3.11
998,7TTY,H,26,IGHV4-39,G,['G' 'S'],Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1,3.11
999,7TTY,H,27,IGHV4-39,G,['G' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1,3.11
1000,7TTY,H,28,IGHV4-39,S,['S' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1,3.11
1001,7TTY,H,30,IGHV4-39,S,['S' 'G'],Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus wiv1,3.11
1002,7TTX,H,1,IGHV4-39,Q,['Q' 'R'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13,2.8
1003,7TTX,H,26,IGHV4-39,G,['G' 'S'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13,2.8
1004,7TTX,H,27,IGHV4-39,G,['G' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13,2.8
1005,7TTX,H,28,IGHV4-39,S,['S' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13,2.8
1006,7TTX,H,30,IGHV4-39,S,['S' 'G'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaGT13 receptor-binding domain,spike glycoprotein,A,bat coronavirus ratg13,2.8
1007,7F15,B,51,IGHV1-3,I,['I' 'S'],A SARS-CoV-2 neutralizing antibody,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.65
1008,4P9H,H,54,IGHV1-69,R,['F' 'L'],Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2,envelope glycoprotein gp160,G,human immunodeficiency virus 1,3.0
1009,4P9H,H,73,IGHV1-69,S,['E' 'K'],Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2,envelope glycoprotein gp160,G,human immunodeficiency virus 1,3.0
1010,3L5X,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the complex between IL-13 and H2L6 FAB,interleukin-13,A,homo sapiens,1.9
1011,3L5Y,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the complex between IL-13 and M1295 FAB,interleukin-13,A,homo sapiens,2.8
1012,4OQT,H,52,IGHV3-23,G,['S' 'Y'],LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens,3.23
1013,4OQT,H,52A,IGHV3-23,P,['G' 'S'],LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens,3.23
1014,4OQT,H,53,IGHV3-23,S,['S' 'G'],LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens,3.23
1015,4OQT,H,55,IGHV3-23,G,['G' 'S'],LINGO-1/Li81 Fab complex,leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 ,A,homo sapiens,3.23
1016,7TTM,H,1,IGHV4-39,Q,['Q' 'R'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014,2.24
1017,7TTM,H,26,IGHV4-39,G,['G' 'S'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014,2.24
1018,7TTM,H,27,IGHV4-39,G,['G' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014,2.24
1019,7TTM,H,28,IGHV4-39,S,['S' 'Y'],Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain,spike protein s1,A,bat sars-like coronavirus rsshc014,2.24
1020,5EA0,H,33,IGHV3-30,G,['A' 'G'],Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens,2.0
1021,5EA0,H,50,IGHV3-30,V,['V' 'F'],Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens,2.0
1022,5EA0,H,52,IGHV3-30,S,['S' 'R'],Structure of the antibody 7968 with human complement factor H-derived peptide,complement factor h-related protein 2,P,homo sapiens,2.0
1023,3KR3,H,50,IGHV3-23,V,['A' 'V'],Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens,2.2
1024,3KR3,H,52,IGHV3-23,S,['S' 'Y'],Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens,2.2
1025,3KR3,H,52A,IGHV3-23,S,['G' 'S'],Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens,2.2
1026,3KR3,H,53,IGHV3-23,S,['S' 'G'],Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens,2.2
1027,3KR3,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of IGF-II antibody complex,insulin-like growth factor ii,D,homo sapiens,2.2
1028,7F1G,D,58,IGHV3-74,T,['S' 'T'],"BACE2 xaperone complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxamide",beta-secretase 2,A,homo sapiens,1.5
1029,7FJC,L,50,IGKV1-5,D,['D' 'K'],Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,2.96
1030,6BQB,H,31,IGHV3-33,D,['S' 'R'],MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum,1.769
1031,6BQB,H,35,IGHV3-33,H,['H' 'Y'],MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum,1.769
1032,6BQB,H,52,IGHV3-33,W,['W' 'S'],MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum,1.769
1033,6BQB,H,94,IGHV3-33,K,['R' 'K'],MGG4 Fab in complex with peptide,n-terminal junction peptide,P,plasmodium falciparum,1.769
1034,6MTO,H,33,IGHV1-69,T,['A' 'T'],Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.634
1035,6MTO,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.634
1036,6MTO,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.634
1037,6MTO,H,56,IGHV1-69,L,['T' 'I'],Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.634
1038,6MTO,H,73,IGHV1-69,T,['E' 'K'],Crystal structure of VRC42.01 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.634
1039,6MTT,H,33,IGHV1-69,T,['A' 'T'],Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1,1.7
1040,6MTT,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1,1.7
1041,6MTT,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1,1.7
1042,6MTT,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1,1.7
1043,6MTT,H,71,IGHV1-69,A,['A' 'T'],Crystal structure of VRC46.01 Fab in complex with gp41 peptide,rv217 founder virus gp41 peptide,P,human immunodeficiency virus 1,1.7
1044,6MTQ,H,33,IGHV1-69,T,['A' 'T'],Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.7
1045,6MTQ,H,50,IGHV1-69,S,['G' 'R'],Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.7
1046,6MTQ,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.7
1047,6MTQ,H,56,IGHV1-69,L,['T' 'I'],Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.7
1048,6MTQ,H,73,IGHV1-69,K,['E' 'K'],Crystal structure of VRC42.N1 Fab in complex with T117-F MPER scaffold,vrc42 epitope t117-f scaffold,T,human immunodeficiency virus 1,2.7
1049,5UCB,L,29,IGKV1-13,V,['G' 'I'],Structure of antigen-Fab complex with engineered switch residue region.,histone chaperone asf1,B,saccharomyces cerevisiae (strain atcc 204508 /s288c) ,1.521
1050,5UCB,L,30,IGKV1-13,S,['I' 'S'],Structure of antigen-Fab complex with engineered switch residue region.,histone chaperone asf1,B,saccharomyces cerevisiae (strain atcc 204508 /s288c) ,1.521
1051,5UCB,L,32,IGKV1-13,A,['S' 'A'],Structure of antigen-Fab complex with engineered switch residue region.,histone chaperone asf1,B,saccharomyces cerevisiae (strain atcc 204508 /s288c) ,1.521
1052,7A3O,L,50,IGLV2-14,D,['E' 'D'],Crystal structure of dengue 1 virus envelope glycoprotein in complex with the scFv fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,dengue virus 1,2.8
1053,7A3O,L,53,IGLV2-14,S,['N' 'K'],Crystal structure of dengue 1 virus envelope glycoprotein in complex with the scFv fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,dengue virus 1,2.8
1054,7A3O,L,60,IGLV2-14,S,['N' 'D'],Crystal structure of dengue 1 virus envelope glycoprotein in complex with the scFv fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,dengue virus 1,2.8
1055,5W6G,H,30,IGHV4-39,K,['S' 'G'],Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands,hemagglutinin ha1,A,influenza a virus (a/solomonislands/3/2006(h1n1)) ,2.79
1056,6GG0,H,33,IGHV4-31,G,['G' 'S'],Cryo-EM structure of BK polyomavirus like particle in complex with single chain antibody ScFv41F17,capsid protein vp1 | capsid protein vp1,4 | 3,bk polyomavirus | bk polyomavirus,4.24
1057,4XNY,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1,2.3
1058,4XNY,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1,2.3
1059,4XNY,H,69,IGHV1-2,M,['S' 'M'],Crystal structure of broadly and potently neutralizing antibody VRC08C in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1,2.3
1060,7YUE,A,50,IGHV3-23,A,['A' 'V'],Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region.,spike protein s2,C,severe acute respiratory syndrome coronavirus2 ,2.35
1061,7YUE,A,52,IGHV3-23,S,['S' 'Y'],Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region.,spike protein s2,C,severe acute respiratory syndrome coronavirus2 ,2.35
1062,7YUE,A,52A,IGHV3-23,R,['G' 'S'],Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region.,spike protein s2,C,severe acute respiratory syndrome coronavirus2 ,2.35
1063,5VAG,C,54,IGHV1-69,F,['F' 'L'],Crystal structure of H7-specific antibody m826 in complex with the HA1 domain of hemagglutinin from H7N9 influenza virus,hemagglutinin,A,influenza a virus,1.9
1064,5VAG,C,56,IGHV1-69,T,['T' 'I'],Crystal structure of H7-specific antibody m826 in complex with the HA1 domain of hemagglutinin from H7N9 influenza virus,hemagglutinin,A,influenza a virus,1.9
1065,7VKE,B,60,IGHV3-30,A,['A' 'T'],Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A,adp-ribosyl cyclase/cyclic adp-ribose hydrolase 1,A,homo sapiens,1.9
1066,6UCE,H,50,IGHV1-2,W,['R' 'W'],N123-VRC34_pI3 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519,hiv fusion peptide,C,human immunodeficiency virus 1,1.382
1067,8ERQ,H,54,IGHV2-5,D,['N' 'D'],SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.3
1068,8ERQ,L,29,IGLV2-14,N,['G' 'S'],SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.3
1069,8ERQ,L,32,IGLV2-14,Y,['Y' 'L'],SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.3
1070,8ERQ,L,50,IGLV2-14,E,['E' 'D'],SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324),spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.3
1071,7T0Z,H,52,IGHV3-23,S,['S' 'Y'],Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens,0
1072,7T0Z,H,52A,IGHV3-23,G,['G' 'S'],Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens,0
1073,7T0Z,H,53,IGHV3-23,S,['S' 'G'],Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens,0
1074,7T0Z,H,55,IGHV3-23,A,['G' 'S'],Complex of GABA-A synaptic receptor with autoimmune antibody Fab175,gamma-aminobutyric acid receptor subunit alpha-1 | gamma-aminobutyric acid receptor subunit gamma-2,D | E,homo sapiens | homo sapiens,0
1075,3GHE,L,29,IGLV2-14,G,['G' 'S'],Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN,envelope glycoprotein,P,,2.4
1076,3GHE,L,32,IGLV2-14,Y,['Y' 'L'],Crystal structure of anti-HIV-1 Fab 537-10D in complex with V3 peptide MN,envelope glycoprotein,P,,2.4
1077,7PRZ,H,26,IGHV3-30,G,['G' 'A'],Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,3.2
1078,7PRZ,H,94,IGHV3-30,K,['R' 'K'],Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs,surface glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,3.2
1079,3IDG,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWD,gp41 mper peptide,C,,1.86
1080,3IDG,A,32,IGKV1-13,A,['S' 'A'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWD,gp41 mper peptide,C,,1.86
1081,3IDG,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ALDKWD,gp41 mper peptide,C,,1.86
1082,6WHK,B,50,IGLV1-51,D,['D' 'E'],Minimally mutated anti-influenza broadly neutralizing antibody,hemagglutinin ha1 chain,A,influenza a virus (a/beijing/262/1995(h1n1)),2.6
1083,7WVG,C,52,IGHV3-30,S,['S' 'R'],Crystal structure of H18 complexed with SIA28,hemagglutinin | hemagglutinin,B | A,influenza a virus | influenza a virus,2.6
1084,7KPG,H,50,IGHV3-23,G,['A' 'V'],Blocking Fab 25 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.27
1085,7KPG,H,52,IGHV3-23,S,['S' 'Y'],Blocking Fab 25 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.27
1086,7KPG,H,53,IGHV3-23,S,['S' 'G'],Blocking Fab 25 anti-SIRP-alpha antibody in complex with SIRP-alpha Variant 1,tyrosine-protein phosphatase non-receptor type substrate 1,S,homo sapiens,2.27
1087,7D0B,H,54,IGHV2-5,D,['N' 'D'],S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
1088,7BBG,H,54,IGHV1-69,F,['F' 'L'],CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens,2.64
1089,7BBG,H,56,IGHV1-69,T,['T' 'I'],CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens,2.64
1090,7BBG,L,50,IGKV1-5,D,['D' 'K'],CRYSTAL STRUCTURE OF HLA-A2-WT1-RMF AND FAB 11D06,mhc class i antigen | wilms tumor 1 (wt1) derived peptide,A | C,homo sapiens | homo sapiens,2.64
1091,7EVW,N,33,IGHV3-48,K,['S' 'E'],Fzd7 -Gs complex,mingas | ggamma | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | C | B,homo sapiens | homo sapiens | homo sapiens,3.22
1092,3BDY,H,54,IGHV3-66,N,['G' 'C'],Dual specific bH1 Fab in complex with VEGF,vascular endothelial growth factor a,V,homo sapiens,2.6
1093,7DX4,H,33,IGHV1-69,A,['A' 'T'],The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.6
1094,7DX4,H,54,IGHV1-69,I,['F' 'L'],The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.6
1095,7DX4,H,56,IGHV1-69,I,['T' 'I'],The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.6
1096,7DX4,H,73,IGHV1-69,K,['E' 'K'],The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.6
1097,7DX4,L,69,IGLV1-40,T,['T' 'A'],The structure of FC08 Fab-hA.CE2-RBD complex,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.6
1098,7LXW,H,31,IGHV3-33,N,['S' 'R'],SARS-CoV-2 S/S2M11/S2X333 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.8
1099,7LXW,H,52,IGHV3-33,W,['W' 'S'],SARS-CoV-2 S/S2M11/S2X333 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.8
1100,7LXW,L,50,IGLV3-21,D,['Y' 'D'],SARS-CoV-2 S/S2M11/S2X333 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,2.8
1101,3DVG,A,29,IGKV1-13,V,['G' 'I'],Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens,2.6
1102,3DVG,A,30,IGKV1-13,S,['I' 'S'],Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens,2.6
1103,3DVG,A,32,IGKV1-13,A,['S' 'A'],Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens,2.6
1104,3DVG,B,54,IGHV3-66,Y,['G' 'C'],Crystal structure of K63-specific fab Apu.3A8 bound to K63-linked di-ubiquitin,ubiquitin | ubiquitin d77,Y | X,homo sapiens | homo sapiens,2.6
1105,4JB9,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.6
1106,4JB9,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.6
1107,6YIO,L,50,IGKV1-5,K,['D' 'K'],CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens,1.83
1108,1NL0,H,33,IGHV3-30,A,['A' 'G'],"Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12",factor ix,G,,2.2
1109,1NL0,H,50,IGHV3-30,I,['V' 'F'],"Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12",factor ix,G,,2.2
1110,1NL0,H,52,IGHV3-30,S,['S' 'R'],"Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12",factor ix,G,,2.2
1111,7XP5,N,33,IGHV3-48,K,['S' 'E'],Cryo-EM structure of a class T GPCR in ligand-free state,guanine nucleotide-binding protein g(t) subunit alpha-3 | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,0
1112,7XP4,N,33,IGHV3-48,K,['S' 'E'],Cryo-EM structure of a class T GPCR in apo state,guanine nucleotide-binding protein g(t) subunit alpha-3 | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,0
1113,7XP6,N,33,IGHV3-48,K,['S' 'E'],Cryo-EM structure of a class T GPCR in active state,guanine nucleotide-binding protein g(t) subunit alpha-3 | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,0
1114,7CE2,Z,33,IGHV4-59,Y,['Y' 'S'],The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani,2.01
1115,7CE2,Z,50,IGHV4-59,Y,['Y' 'R'],The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani,2.01
1116,7CE2,Z,53,IGHV4-59,Y,['Y' 'T'],The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani,2.01
1117,7CE2,Z,58,IGHV4-59,N,['N' 'Y'],The Crystal structure of TeNT Hc complexed with neutralizing antibody,tetanus toxin,A,clostridium tetani,2.01
1118,5WB9,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of CD4 binding site antibody N60P23 in complex with HIV-1 clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.4
1119,5WB9,H,61,IGHV1-2,G,['Q' 'H'],Crystal structure of CD4 binding site antibody N60P23 in complex with HIV-1 clade A/E strain 93TH057 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.4
1120,4JB9,L,96,IGKV3D-20,E,['Y' 'R'],Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.6
1121,4JB9,L,97,IGKV3D-20,F,['G' 'S'],Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.6
1122,7WY5,N,33,IGHV3-48,K,['S' 'E'],ADGRL3/Gq complex,engineered mini g alpha q subunit | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1 ,A | B,homo sapiens | homo sapiens,2.83
1123,3D0L,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671,hyb3k peptide construct,C,,2.35
1124,3D0L,A,32,IGKV1-13,A,['S' 'A'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671,hyb3k peptide construct,C,,2.35
1125,3D0L,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671,hyb3k peptide construct,C,,2.35
1126,5VGJ,H,31,IGHV3-13,D,['S' 'N'],"Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain",1fd6-v1v2-wito,G,human immunodeficiency virus 1,3.456
1127,6YIO,H,33,IGHV1-69,A,['A' 'T'],CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens,1.83
1128,6YIO,H,54,IGHV1-69,F,['F' 'L'],CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens,1.83
1129,6YIO,H,73,IGHV1-69,E,['E' 'K'],CRYSTAL STRUCTURE OF FAB RG6292 IN COMPLEX WITH CD25 ECD,interleukin-2 receptor subunit alpha,B,homo sapiens,1.83
1130,6WFY,H,31,IGHV3-49,D,['D' 'Y'],Crystal structure of Fab224 in complex with NPNA4 peptide from circumsporozoite protein,npna4 peptide,P,plasmodium falciparum,1.226
1131,6WFY,H,33,IGHV3-49,A,['A' 'P'],Crystal structure of Fab224 in complex with NPNA4 peptide from circumsporozoite protein,npna4 peptide,P,plasmodium falciparum,1.226
1132,6WFX,H,31,IGHV3-33,S,['S' 'R'],Crystal structure of Fab395 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,2.59
1133,6WFX,H,52,IGHV3-33,W,['W' 'S'],Crystal structure of Fab395 in complex with NPNA2 peptide from circumsporozoite protein,npna2 peptide,P,plasmodium falciparum,2.59
1134,7X8W,H,50,IGHV1-2,W,['R' 'W'],The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,0
1135,5VZY,H,50,IGHV3-23,S,['A' 'V'],Crystal structure of crenezumab Fab in complex with Abeta,amyloid beta,A,homo sapiens,2.32
1136,5VZY,H,52,IGHV3-23,N,['S' 'Y'],Crystal structure of crenezumab Fab in complex with Abeta,amyloid beta,A,homo sapiens,2.32
1137,5VZY,H,52A,IGHV3-23,S,['G' 'S'],Crystal structure of crenezumab Fab in complex with Abeta,amyloid beta,A,homo sapiens,2.32
1138,2B4C,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody,envelope glycoprotein | t-cell surface glycoprotein cd4,G | C,human immunodeficiency virus 1 | homo sapiens,3.3
1139,2B4C,H,56,IGHV1-69,T,['T' 'I'],Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) complexed with CD4 and the X5 antibody,envelope glycoprotein | t-cell surface glycoprotein cd4,G | C,human immunodeficiency virus 1 | homo sapiens,3.3
1140,8DCE,H,32,IGLV2-14,Y,['Y' 'L'],SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2
1141,7F7E,C,53,IGHV3-23,S,['S' 'G'],SARS-CoV-2 S protein RBD in complex with A5-10 Fab,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,2.49
1142,3UJJ,L,50,IGLV3-10,E,['E' 'K'],Crystal structure of anti-HIV-1 V3 Fab 4025 in complex with Con A peptide,gp120,P,human immunodeficiency virus 1,2.0
1143,3UJJ,L,96,IGLV3-10,F,['T' 'A'],Crystal structure of anti-HIV-1 V3 Fab 4025 in complex with Con A peptide,gp120,P,human immunodeficiency virus 1,2.0
1144,6AL5,H,33,IGHV1-69,W,['A' 'T'],COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB,b-lymphocyte antigen cd19,A,homo sapiens,3.0
1145,6AL5,H,54,IGHV1-69,D,['F' 'L'],COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB,b-lymphocyte antigen cd19,A,homo sapiens,3.0
1146,6AL5,H,56,IGHV1-69,D,['T' 'I'],COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB,b-lymphocyte antigen cd19,A,homo sapiens,3.0
1147,6AL5,H,73,IGHV1-69,E,['E' 'K'],COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB,b-lymphocyte antigen cd19,A,homo sapiens,3.0
1148,4YDI,H,50,IGHV1-2,W,['R' 'W'],"Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17",envelope glycoprotein gp160,G,human immunodeficiency virus 1,3.452
1149,4YDI,H,61,IGHV1-2,H,['Q' 'H'],"Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17",envelope glycoprotein gp160,G,human immunodeficiency virus 1,3.452
1150,4YDI,L,32,IGKV1-13,D,['S' 'A'],"Crystal structure of broad and potently neutralizing VRC01-class antibody Z258-VRC27.01, isolated from human donor Z258, in complex with HIV-1 gp120 from clade A strain Q23.17",envelope glycoprotein gp160,G,human immunodeficiency virus 1,3.452
1151,4YDK,H,52A,IGHV3-23,A,['G' 'S'],Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160",G,human immunodeficiency virus 1,2.051
1152,4YDK,H,53,IGHV3-23,H,['S' 'G'],Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160",G,human immunodeficiency virus 1,2.051
1153,4YDK,H,55,IGHV3-23,G,['G' 'S'],Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 clade AE strain 93TH057 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160",G,human immunodeficiency virus 1,2.051
1154,5Y9J,H,54,IGHV1-69,F,['F' 'L'],BAFF in complex with belimumab,tumor necrosis factor ligand superfamily member 13b,A,homo sapiens,2.05
1155,5Y9J,H,56,IGHV1-69,T,['T' 'I'],BAFF in complex with belimumab,tumor necrosis factor ligand superfamily member 13b,A,homo sapiens,2.05
1156,5IGX,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120,426c.tm1deltav1-3 gp120,G,human immunodeficiency virus 1,3.39
1157,5IGX,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of NIH45-46 Fab germline precursor in complex with 426c.TM1deltaV1-3 gp120,426c.tm1deltav1-3 gp120,G,human immunodeficiency virus 1,3.39
1158,7SK9,F,50,IGHV3-23,S,['A' 'V'],"Cryo-EM structure of human ACKR3 in complex with a small molecule partial agonist CCX662, and an intracellular Fab",atypical chemokine receptor 3,A,homo sapiens,0
1159,7SK9,F,52,IGHV3-23,S,['S' 'Y'],"Cryo-EM structure of human ACKR3 in complex with a small molecule partial agonist CCX662, and an intracellular Fab",atypical chemokine receptor 3,A,homo sapiens,0
1160,7SK9,F,53,IGHV3-23,S,['S' 'G'],"Cryo-EM structure of human ACKR3 in complex with a small molecule partial agonist CCX662, and an intracellular Fab",atypical chemokine receptor 3,A,homo sapiens,0
1161,7SK6,F,50,IGHV3-23,S,['A' 'V'],Cryo-EM structure of human ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ and an intracellular Fab,atypical chemokine receptor 3,A,homo sapiens,4.0
1162,7SK6,F,52,IGHV3-23,S,['S' 'Y'],Cryo-EM structure of human ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ and an intracellular Fab,atypical chemokine receptor 3,A,homo sapiens,4.0
1163,7SK6,F,53,IGHV3-23,S,['S' 'G'],Cryo-EM structure of human ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ and an intracellular Fab,atypical chemokine receptor 3,A,homo sapiens,4.0
1164,5KJR,H,33,IGHV4-31,G,['G' 'S'],Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.98
1165,5KJR,L,29,IGLV2-14,G,['G' 'S'],Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.98
1166,5KJR,L,32,IGLV2-14,Y,['Y' 'L'],Crystal structure of the ADCC-potent antibody N60-i3 Fab in complex with HIV-1 Clade A/E gp120 W69A/S115W mutant and M48U1.,clade a/e 93th057 hiv-1 gp120 core,G,human immunodeficiency virus 1,2.98
1167,6UOE,H,52,IGHV3-30,S,['S' 'R'],3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide,envelope glycoprotein b,P,human betaherpesvirus 5,1.8
1168,6UOE,H,94,IGHV3-30,R,['R' 'K'],3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide,envelope glycoprotein b,P,human betaherpesvirus 5,1.8
1169,3MOD,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced IgG) with 11 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,homo sapiens,2.2
1170,3MOA,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) with 17 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,,2.3
1171,3MOB,H,54,IGHV2-5,D,['N' 'D'],Crystal structure of the neutralizing HIV antibody 2F5 Fab fragment (recombinantly produced Fab) with 11 aa gp41 MPER-derived peptide,gp41 mper-derived peptide,P,,2.6
1172,4LSU,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1,2.3
1173,4LSU,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1,2.3
1174,4LSV,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120,envelope glycoprotein gp120,G,human immunodeficiency virus 1,3.0
1175,4LSV,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120,envelope glycoprotein gp120,G,human immunodeficiency virus 1,3.0
1176,4LSV,H,69,IGHV1-2,L,['S' 'M'],Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120,envelope glycoprotein gp120,G,human immunodeficiency virus 1,3.0
1177,4LSQ,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1,envelope glycoprotein gp120 with loop d and v5 from strain3415_v1_c1 ,G,human immunodeficiency virus 1,2.25
1178,4LSQ,H,61,IGHV1-2,W,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1,envelope glycoprotein gp120 with loop d and v5 from strain3415_v1_c1 ,G,human immunodeficiency virus 1,2.25
1179,4LSP,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1,2.15
1180,4LSP,H,61,IGHV1-2,W,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057,hiv-1 clade a/e strain 93th057 gp120,G,human immunodeficiency virus 1,2.15
1181,4LSR,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11,envelope glycoprotein gp120 with loop d and v5 from strainker_2018_11 ,G,human immunodeficiency virus 1,2.28
1182,4LSR,H,61,IGHV1-2,W,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11,envelope glycoprotein gp120 with loop d and v5 from strainker_2018_11 ,G,human immunodeficiency virus 1,2.28
1183,7DAA,L,50,IGKV1-5,D,['D' 'K'],Crystal structure of basigin complexed with anti-basigin Fab fragment,isoform 2 of basigin,A,homo sapiens,2.51
1184,7CDJ,H,54,IGHV3-11,G,['G' 'S'],Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.396
1185,7CDJ,H,56,IGHV3-11,T,['T' 'Y'],Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.396
1186,7CDJ,H,58,IGHV3-11,Y,['Y' 'N'],Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.396
1187,7CDI,H,54,IGHV3-66,G,['G' 'C'],Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,2.96
1188,7MZL,H,26,IGHV4-34,G,['G' 'F'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1189,7MZL,H,27,IGHV4-34,E,['G' 'S'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1190,7MZL,H,28,IGHV4-34,T,['S' 'T' 'G'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1191,7MZL,H,30,IGHV4-34,S,['S' 'Y'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1192,7MZL,H,31,IGHV4-34,G,['G' 'W'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1193,7MZL,H,32,IGHV4-34,Y,['Y' 'S'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1194,7MZL,H,50,IGHV4-34,E,['E' 'Y'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1195,7MZL,H,52,IGHV4-34,S,['N' 'Y' 'I'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1196,7MZL,H,53,IGHV4-34,L,['H' 'Y'],SARS-CoV-2 receptor binding domain bound to Fab PDI 210,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.7
1197,7MZM,H,54,IGHV3-11,S,['G' 'S'],SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.3
1198,7MZM,H,56,IGHV3-11,F,['T' 'Y'],SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.3
1199,7MZM,H,57,IGHV3-11,T,['I' 'T'],SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.3
1200,7MZM,H,58,IGHV3-11,N,['Y' 'N'],SARS-CoV-2 receptor binding domain bound to Fab PDI 215,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.3
1201,4NZR,H,1,IGHV4-39,Q,['Q' 'R'],Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-HIV antibody PGT135 Fab,protein m td,M,mycoplasma genitalium,1.65
1202,4NZR,H,26,IGHV4-39,G,['G' 'S'],Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-HIV antibody PGT135 Fab,protein m td,M,mycoplasma genitalium,1.65
1203,4NZR,H,27,IGHV4-39,D,['G' 'Y'],Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-HIV antibody PGT135 Fab,protein m td,M,mycoplasma genitalium,1.65
1204,4NZT,L,43,IGLV1-44,A,['A' 'G'],Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-infleunza hemagglutinin antibody CR9114 Fab,protein m td,M,mycoplasma genitalium,2.497
1205,4NZT,L,59,IGLV1-44,P,['P' 'L'],Crystal structure of the antibody-binding region of Protein M (Protein M TD) in complex with anti-infleunza hemagglutinin antibody CR9114 Fab,protein m td,M,mycoplasma genitalium,2.497
1206,3DRO,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 Cross Neutralizing Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN grown in ammonium sulfate,elleldkwaslwn gp41 peptide,P,,3.9
1207,3DRO,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Antibody 2F5 in complex with gp41 Peptide ELLELDKWASLWN grown in ammonium sulfate,elleldkwaslwn gp41 peptide,P,,3.9
1208,3P30,L,50,IGLV1-47,K,['R' 'S'],crystal structure of the cluster II Fab 1281 in complex with HIV-1 gp41 ectodomain,hiv-1 gp41,A,human immunodeficiency virus 1,3.3
1209,3DRQ,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671 soaked in PEG/2-propanol solution,gp41 peptide epitope,C,,2.0
1210,3DRT,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 scrambledFP-MPER scrHyb3K construct GIGAFGLLGFLAAGSKK-Ahx-K656NEQELLELDKWASLWN671,scrhyb3k construct,C,,3.3
1211,7WE8,H,54,IGHV2-5,D,['N' 'D'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.5
1212,7WE8,L,29,IGLV2-14,G,['G' 'S'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.5
1213,7WE8,L,32,IGLV2-14,Y,['Y' 'L'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.5
1214,7WE8,L,50,IGLV2-14,E,['E' 'D'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.5
1215,7WE8,L,60,IGLV2-14,N,['N' 'D'],SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265,spike glycoprotein | spike glycoprotein | spike glycoprotein,A | C | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,3.5
1216,6XY2,H,50,IGHV4-59,Y,['Y' 'R'],Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens,3.05
1217,6XY2,H,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens,3.05
1218,6XY2,H,58,IGHV4-59,N,['N' 'Y'],Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody,cytotoxic t-lymphocyte protein 4,A,homo sapiens,3.05
1219,7WEE,H,54,IGHV2-5,D,['N' 'D'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,4
1220,7WEE,L,32,IGLV2-14,Y,['Y' 'L'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265,spike glycoprotein,E,severe acute respiratory syndrome coronavirus2 ,4
1221,7WED,H,34,IGHV1-58,S,['V' 'M'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,3.5
1222,5IES,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.16 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens,2.16
1223,5IES,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of VRC01c-HuGL2 Fab from an HIV-1 naive donor in complex with with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.16 A,germline-targeting hiv-1 gp120 engineered outer domain eod-gt8 ,C,homo sapiens,2.16
1224,6WDS,L,50,IGLV1-47,K,['R' 'S'],Enterovirus D68 in complex with human monoclonal antibody EV68-159,viral protein 3 | viral protein 1 | viral protein 2,C | A | B,enterovirus d68 | enterovirus d68 | enterovirus d68,2.9
1225,4EDW,H,31,IGHV4-4,G,['S' 'N'],Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens,2.48
1226,4EDW,H,32,IGHV4-4,Y,['S' 'W' 'Y'],Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens,2.48
1227,4EDW,H,33,IGHV4-4,D,['N' 'W' 'Y'],Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens,2.48
1228,4EDW,H,53,IGHV4-4,G,['H' 'T'],Nerve Growth Factor in Complex with Fab from humanized version of mouse mAb 911 (tanezumab),beta-nerve growth factor,V,homo sapiens,2.48
1229,7KTX,I,25,IGHV4-34,Y,['Y' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1230,7KTX,I,26,IGHV4-34,G,['G' 'F'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1231,7KTX,I,27,IGHV4-34,G,['G' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1232,7KTX,I,28,IGHV4-34,S,['S' 'T' 'G'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1233,7KTX,I,29,IGHV4-34,F,['F' 'V' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1234,7KTX,I,30,IGHV4-34,S,['S' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1235,7KTX,I,31,IGHV4-34,G,['G' 'W'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1236,7KTX,I,32,IGHV4-34,Y,['Y' 'S'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1237,7KTX,I,52,IGHV4-34,N,['N' 'Y' 'I'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1238,7KTX,I,53,IGHV4-34,H,['H' 'Y'],Cryo-EM structure of Saccharomyces cerevisiae ER membrane protein complex bound to a Fab in DDM detergent,er membrane protein complex subunit 1,A,saccharomyces cerevisiae by4743,4.3
1239,7MZF,H,54,IGHV3-66,G,['G' 'C'],SARS-CoV-2 receptor binding domain bound to Fab PDI 37,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.493
1240,7MZG,H,54,IGHV3-66,G,['G' 'C'],SARS-CoV-2 receptor binding domain bound to Fab PDI 42,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,2.0
1241,7MZI,H,50,IGHV3-23,A,['A' 'V'],SARS-CoV-2 receptor binding domain bound to Fab WCSL 129,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.85
1242,7MZI,H,52,IGHV3-23,S,['S' 'Y'],SARS-CoV-2 receptor binding domain bound to Fab WCSL 129,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,1.85
1243,7SIX,H,33,IGHV4-31,N,['G' 'S'],Antibody N3-1 bound to RBDs in the up and down conformations,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
1244,7SIX,H,73,IGHV4-31,T,['T' 'K' 'P'],Antibody N3-1 bound to RBDs in the up and down conformations,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,0
1245,7KI1,N,33,IGHV3-48,K,['S' 'E'],Taspoglutide-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in Complex with Gs Protein,guanine nucleotide-binding protein g(s) subunit alphaisoforms short  | guanine nucleotide-binding protein g(i)/g(s)/g(t) subunitbeta-1  | guanine nucleotide-binding protein g(i)/g(s)/g(o) subunitgamma-2 ,A | B | G,homo sapiens | homo sapiens | homo sapiens,2.5
1246,3LEV,H,54,IGHV2-5,D,['N' 'D'],HIV-1 antibody 2F5 in complex with epitope scaffold ES2,rna polymerase sigma factor,A,thermus aquaticus,2.5
1247,3P11,H,58,IGHV3-74,D,['S' 'T'],anti-EGFR/HER3 Fab DL11 in complex with domains I-III of the HER3 extracellular region,receptor tyrosine-protein kinase erbb-3,A,homo sapiens,3.7
1248,6PDU,L,27D,IGKV2-30,H,['Y' 'H'],Vaccine-elicited NHP FP-targeting antibody 13N024-a.01 in complex with HIV fusion peptide (residue 512-519),hiv-1 fusion peptide residue 512-519,C,human immunodeficiency virus 1,1.953
1249,4JDT,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1,3.26
1250,4JDT,H,61,IGHV1-2,Q,['Q' 'H'],Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1,3.26
1251,4JDT,H,69,IGHV1-2,M,['S' 'M'],Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 HIV-1,gp120,G,human immunodeficiency virus 1,3.26
1252,1RZK,H,54,IGHV1-69,L,['F' 'L'],HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.9
1253,1RZK,H,56,IGHV1-69,V,['T' 'I'],HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.9
1254,1RZJ,H,54,IGHV1-69,L,['F' 'L'],HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.2
1255,1RZJ,H,56,IGHV1-69,V,['T' 'I'],HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.2
1256,2XRA,H,33,IGHV1-69,A,['A' 'T'],crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct,2.3
1257,2XRA,H,54,IGHV1-69,F,['F' 'L'],crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct,2.3
1258,2XRA,H,56,IGHV1-69,I,['T' 'I'],crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix,transmembrane protein gp41,A,synthetic construct,2.3
1259,4FQJ,L,50,IGLV1-47,R,['R' 'S'],Influenza B/Florida/4/2006 hemagglutinin Fab CR8071 complex,hemagglutinin,A,influenza b virus,2.5
1260,6UKJ,H,54,IGHV3-66,S,['G' 'C'],Single-Particle Cryo-EM Structure of Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT) 7G8 Isoform,chloroquine resistance transporter,A,plasmodium falciparum (isolate 7g8),3.3
1261,7CHZ,H,50,IGHV3-23,R,['A' 'V'],Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26A,interleukin-1 beta,I,homo sapiens,2.5
1262,7CHZ,H,52,IGHV3-23,W,['S' 'Y'],Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26A,interleukin-1 beta,I,homo sapiens,2.5
1263,7CHZ,H,55,IGHV3-23,G,['G' 'S'],Crystal Structure Of Human Il-1beta In Complex With Antibody Binding Fragment Of IgG26A,interleukin-1 beta,I,homo sapiens,2.5
1264,6Q0L,H,26,IGHV4-4,G,['G' 'S'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1265,6Q0L,H,27,IGHV4-4,G,['G' 'I'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1266,6Q0L,H,31,IGHV4-4,S,['S' 'N'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1267,6Q0L,H,32,IGHV4-4,S,['S' 'W' 'Y'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1268,6Q0L,H,33,IGHV4-4,N,['N' 'W' 'Y'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1269,6Q0L,H,34,IGHV4-4,W,['W' 'S'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1270,6Q0L,H,53,IGHV4-4,H,['H' 'T'],Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.5
1271,4N0Y,H,51,IGHV1-3,I,['I' 'S'],Structure of the Hepatitis C Envelope Glycoprotein E1 antigenic region 314-324 bound to the cross-neutralizing antibody IGH526,hcv e1 peptide,A,hepatitis c virus,1.749
1272,6W7S,H,26,IGHV3-30,G,['G' 'A'],Ketoreductase from module 1 of the 6-deoxyerythronolide B synthase (KR1) in complex with antibody fragment (Fab) 2G10,eryai,A,saccharopolyspora erythraea,2.25
1273,5TFW,H,50,IGHV3-15,R,['R' 'C'],"Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold",10e8 epitope scaffold t117v2,O,synthetic construct,2.168
1274,5TFW,H,52,IGHV3-15,T,['K' 'E'],"Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold",10e8 epitope scaffold t117v2,O,synthetic construct,2.168
1275,5TFW,H,52C,IGHV3-15,G,['T' 'A'],"Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold",10e8 epitope scaffold t117v2,O,synthetic construct,2.168
1276,5TFW,H,53,IGHV3-15,E,['D' 'N'],"Crystal structure of 10E8 Fab light chain mutant2 against the MPER region of the HIV-1 Env, in complex with T117v2 epitope scaffold",10e8 epitope scaffold t117v2,O,synthetic construct,2.168
1277,1U95,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide ELDHWAS,gp41 peptide,C,human immunodeficiency virus 1,2.24
1278,1U91,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog ENDKW-[Dap]-S (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1,2.24
1279,1U93,A,30,IGKV1-13,T,['I' 'S'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog EQDKW-[Dap]-S (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1,2.37
1280,1U93,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog EQDKW-[Dap]-S (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1,2.37
1281,1U92,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide Analog E-[Dap]-DKWQS (cyclic),gp41 peptide analog,C,human immunodeficiency virus 1,2.24
1282,4G6J,H,31,IGHV3-33,V,['S' 'R'],Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab,interleukin-1 beta,A,homo sapiens,2.03
1283,4G6J,H,52,IGHV3-33,W,['W' 'S'],Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab,interleukin-1 beta,A,homo sapiens,2.03
1284,4G6J,H,94,IGHV3-33,R,['R' 'K'],Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab,interleukin-1 beta,A,homo sapiens,2.03
1285,4G6M,H,54,IGHV2-5,D,['N' 'D'],Crystal strucure of human IL-1beta in complex with therapeutic antibody binding fragment of gevokizumab,interleukin-1 beta,A,homo sapiens,1.81
1286,7SOD,H,26,IGHV3-30,G,['G' 'A'],SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.2
1287,7SOD,H,33,IGHV3-30,G,['A' 'G'],SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.2
1288,7SOD,H,52,IGHV3-30,R,['S' 'R'],SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.2
1289,7SO5,H,30,IGHV4-34,S,['S' 'Y'],Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291,1.797
1290,7SO5,H,31,IGHV4-34,E,['G' 'W'],Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291,1.797
1291,7SO5,H,32,IGHV4-34,H,['Y' 'S'],Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291,1.797
1292,7SO5,H,52,IGHV4-34,N,['N' 'Y' 'I'],Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291,1.797
1293,7SO5,H,53,IGHV4-34,Y,['H' 'Y'],Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B,toxin b,A,clostridioides difficile r20291,1.797
1294,4RQS,D,54,IGHV1-69,L,['F' 'L'],Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab,hiv-1 yu2 gp120 core chimeric protein,G,homo sapiens,4.493
1295,4RQS,D,56,IGHV1-69,V,['T' 'I'],Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab,hiv-1 yu2 gp120 core chimeric protein,G,homo sapiens,4.493
1296,4DGY,H,52,IGHV3-33,W,['W' 'S'],"Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the broadly neutralizing antibody HCV1, C2 form",e2 peptide,A,hepatitis c virus,1.798
1297,4DGV,H,52,IGHV3-33,W,['W' 'S'],"Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the broadly neutralizing antibody HCV1, P2(1) form",e2 peptide,A,hepatitis c virus,1.805
1298,6R2S,A,50,IGKV1-5,K,['D' 'K'],The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i),3.04
1299,6R2S,B,1,IGHV4-39,E,['Q' 'R'],The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i),3.04
1300,6R2S,B,26,IGHV4-39,G,['G' 'S'],The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i),3.04
1301,6R2S,B,27,IGHV4-39,G,['G' 'Y'],The structure of Plasmodium vivax Duffy binding protein (PvDBP) bound to human antibody DB9,duffy receptor,C,plasmodium vivax (strain salvador i),3.04
1302,4RWY,H,30,IGHV1-46,N,['T' 'N'],Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC131 in complex with HIV-1 clade B YU2 gp120,hiv-1 yu2 gp120,A,human immunodeficiency virus 1,2.128
1303,2YSS,B,27,IGHV4-59,D,['G' 'I'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1304,2YSS,B,30,IGHV4-59,R,['S' 'Y'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1305,2YSS,B,31,IGHV4-59,S,['S' 'Y'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1306,2YSS,B,32,IGHV4-59,D,['Y' 'W' 'H'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1307,2YSS,B,33,IGHV4-59,Y,['Y' 'S'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1308,2YSS,B,50,IGHV4-59,Y,['Y' 'R'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1309,2YSS,B,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1310,2YSS,B,58,IGHV4-59,Y,['N' 'Y'],Crystal structure of Humanized HYHEL-10 FV mutant(HQ39KW47Y)-HEN lysozyme complex,lysozyme c,C,gallus gallus,2.4
1311,7DK0,A,50,IGHV1-69,R,['G' 'R'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,3.199
1312,7DK0,A,54,IGHV1-69,F,['F' 'L'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,3.199
1313,7DK0,A,56,IGHV1-69,S,['T' 'I'],Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,3.199
1314,6MEH,H,33,IGHV1-69,A,['A' 'T'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,1.99
1315,6MEH,H,54,IGHV1-69,S,['F' 'L'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,1.99
1316,6MEI,H,33,IGHV1-69,E,['A' 'T'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,2.9
1317,6MEI,H,54,IGHV1-69,I,['F' 'L'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,2.9
1318,6MEI,H,56,IGHV1-69,E,['T' 'I'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,2.9
1319,6MEI,H,73,IGHV1-69,E,['E' 'K'],Broadly neutralizing antibodies against HCV use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design,e2 glycoprotein,C,hepacivirus c,2.9
1320,4I77,H,33,IGHV2-70,S,['G' 'E'],Lebrikizumab Fab bound to IL-13,interleukin-13,Z,homo sapiens,1.9
1321,7XXL,C,32,IGLV2-14,Y,['Y' 'L'],RBD in complex with Fab14,spike protein s1,B,severe acute respiratory syndrome coronavirus2 ,0
1322,7N0A,B,29,IGHV3-15,F,['F' 'C'],Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens,3.1
1323,7N0A,B,52,IGHV3-15,K,['K' 'E'],Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens,3.1
1324,7N0A,B,52C,IGHV3-15,S,['T' 'A'],Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens,3.1
1325,7N0A,B,53,IGHV3-15,D,['D' 'N'],Structure of Human Leukaemia Inhibitory Factor with Fab MSC1,leukemia inhibitory factor,C,homo sapiens,3.1
1326,2B0S,L,50,IGLV1-47,R,['R' 'S'],Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide,mn peptide of exterior membrane glycoprotein gp120,P,,2.3
1327,7SSC,H,33,IGHV3-30,N,['A' 'G'],TRL345 lineage ancestor I8 Fab bound to an HCMV gB-derived peptide,envelope glycoprotein b peptide,P,human betaherpesvirus 5,1.8
1328,7SSC,H,52,IGHV3-30,S,['S' 'R'],TRL345 lineage ancestor I8 Fab bound to an HCMV gB-derived peptide,envelope glycoprotein b peptide,P,human betaherpesvirus 5,1.8
1329,7SSC,H,94,IGHV3-30,R,['R' 'K'],TRL345 lineage ancestor I8 Fab bound to an HCMV gB-derived peptide,envelope glycoprotein b peptide,P,human betaherpesvirus 5,1.8
1330,5XWD,D,50,IGLV3-21,Y,['Y' 'D'],Crystal structure of the complex of 059-152-Fv and EGFR-ECD,epidermal growth factor receptor,A,homo sapiens,2.8939999999999997
1331,5XWD,H,30,IGHV4-39,S,['S' 'G'],Crystal structure of the complex of 059-152-Fv and EGFR-ECD,epidermal growth factor receptor,A,homo sapiens,2.8939999999999997
1332,2FX7,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,,1.76
1333,2FX7,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,,1.76
1334,2FX7,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,,1.76
1335,2FX7,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of hiv-1 neutralizing human fab 4e10 in complex with a 16-residue peptide encompassing the 4e10 epitope on gp41,fragment of hiv glycoprotein (gp41),P,,1.76
1336,2NXY,D,54,IGHV1-69,L,['F' 'L'],HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b,envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
1337,2NXY,D,56,IGHV1-69,V,['T' 'I'],HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b,envelope glycoprotein gp120,A,human immunodeficiency virus 1,2.0
1338,7KCR,H,50,IGHV3-30,F,['V' 'F'],Cryo-EM structure of Zika virus in complex with E protein cross-linking human monoclonal antibody ADI30056,envelope protein e | envelope protein e | envelope protein e,C | A | E,zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013 ,4
1339,7KCR,H,52,IGHV3-30,R,['S' 'R'],Cryo-EM structure of Zika virus in complex with E protein cross-linking human monoclonal antibody ADI30056,envelope protein e | envelope protein e | envelope protein e,C | A | E,zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013  | zika virus zikv/h.sapiens/frenchpolynesia/10087pf/2013 ,4
1340,6TOU,A,33,IGHV4-31,S,['G' 'S'],Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20,"glycoprotein,glycoprotein",G,rabies lyssavirus,2.587
1341,6TOU,A,50,IGHV4-31,Y,['Y' 'C'],Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20,"glycoprotein,glycoprotein",G,rabies lyssavirus,2.587
1342,4XBE,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1,1.756
1343,4XBE,H,50,IGHV1-69,G,['G' 'R'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1,1.756
1344,4XBE,H,54,IGHV1-69,L,['F' 'L'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1,1.756
1345,4XBE,H,56,IGHV1-69,I,['T' 'I'],Crystal structure of human 4E10 Fab in complex with its peptide epitope on HIV-1 gp41: crystals cryoprotected with sphingomyelin (02:0 SM (d18:1/2:0)).,peptide fragment of hiv glycoprotein (gp41) including theregion 671-683 of the mper ,P,human immunodeficiency virus 1,1.756
1346,4JHW,H,54,IGHV1-69,L,['F' 'L'],Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25,fusion glycoprotein f0,F,human respiratory syncytial virus,3.6
1347,7WON,H,94,IGHV3-30,R,['R' 'K'],Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local refinement),spike protein s1,F,severe acute respiratory syndrome coronavirus2 ,3.9
1348,7WOG,A,52,IGHV3-23,S,['S' 'Y'],SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1349,7WOG,A,53,IGHV3-23,S,['S' 'G'],SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1350,7WOG,A,55,IGHV3-23,G,['G' 'S'],SARS-CoV-2 Omicron S monomer complexed with 553-49,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1351,7WOC,A,54,IGHV1-69,L,['F' 'L'],"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1352,7WOC,A,56,IGHV1-69,I,['T' 'I'],"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1353,7WOC,A,73,IGHV1-69,K,['E' 'K'],"S-mAb60 NRAb1 local-refined map"""" into """"Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60",spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,0
1354,7DM2,L,50,IGLV1-47,R,['R' 'S'],crystal structure of the M. tuberculosis phosphate ABC transport receptor PstS-1 in complex with Fab p4-170,phosphate-binding protein psts 1,A,mycobacterium tuberculosis h37rv,2.4
1355,7BSC,H,33,IGHV4-31,Y,['G' 'S'],Complex structure of 1G5.3 Fab bound to DENV2 NS1c,non-structural protein 1,A,dengue virus 2,2.31
1356,6VC9,H,31,IGHV4-4,N,['S' 'N'],TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens,2.25
1357,6VC9,H,32,IGHV4-4,N,['S' 'W' 'Y'],TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens,2.25
1358,6VC9,H,33,IGHV4-4,Y,['N' 'W' 'Y'],TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens,2.25
1359,6VC9,H,50,IGHV4-4,R,['E' 'R' 'Y'],TB19 complex,"5'-nucleotidase, ecto (cd73), isoform cra_a",A,homo sapiens,2.25
1360,4Z0X,B,33,IGHV1-69,V,['A' 'T'],Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus,2.0
1361,4Z0X,B,50,IGHV1-69,G,['G' 'R'],Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus,2.0
1362,4Z0X,B,54,IGHV1-69,F,['F' 'L'],Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus,2.0
1363,4Z0X,B,56,IGHV1-69,T,['T' 'I'],Structure of Hepatitis C Virus Envelope glycoprotein E2 antigenic region 434-446 bound to the broadly neutralizing antibody HC26AM,hcv e2 antigen (residues 432-446),C,hepatitis c virus,2.0
1364,7RP3,H,26,IGHV4-4,G,['G' 'S'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1365,7RP3,H,27,IGHV4-4,G,['G' 'I'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1366,7RP3,H,31,IGHV4-4,S,['S' 'N'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1367,7RP3,H,32,IGHV4-4,S,['S' 'W' 'Y'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1368,7RP3,H,33,IGHV4-4,N,['N' 'W' 'Y'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1369,7RP3,H,53,IGHV4-4,H,['H' 'T'],Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP,isoform 2b of gtpase kras,A,homo sapiens,2.0
1370,2VXQ,H,33,IGHV4-31,G,['G' 'S'],Crystal structure of the major grass pollen allergen Phl p 2 in  complex with its specific IgE-Fab,pollen allergen phl p 2,A,phleum pratense,1.9
1371,6W16,H,26,IGHV3-30,G,['G' 'A'],Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab,"fusion glycoprotein f0,envelope glycoprotein fusion",F,"human metapneumovirus, human immunodeficiencyvirus 1 ",3.1
1372,6W16,H,33,IGHV3-30,G,['A' 'G'],Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab,"fusion glycoprotein f0,envelope glycoprotein fusion",F,"human metapneumovirus, human immunodeficiencyvirus 1 ",3.1
1373,6W16,H,52,IGHV3-30,V,['S' 'R'],Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab,"fusion glycoprotein f0,envelope glycoprotein fusion",F,"human metapneumovirus, human immunodeficiencyvirus 1 ",3.1
1374,3RU8,H,52A,IGHV1-3,P,['A' 'T'],Structure of an HIV epitope scaffold in complex with neutralizing antibody b12 Fab,epitope scaffold 2bodx43,X,"human immunodeficiency virus, syntheticconstruct, thermomonospora fusca ",2.07
1375,7MRZ,X,28,IGHV4-39,S,['S' 'Y'],Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment,"activin receptor type-2b,activin receptor type-1b",C,homo sapiens,3.0
1376,7MRZ,X,30,IGHV4-39,S,['S' 'G'],Structure of GDF11 bound to fused ActRIIB-ECD and Alk4-ECD with Anti-ActRIIB Fab fragment,"activin receptor type-2b,activin receptor type-1b",C,homo sapiens,3.0
1377,8DFH,H,50,IGHV3-30,Y,['V' 'F'],Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,2.3
1378,8DFH,H,52,IGHV3-30,R,['S' 'R'],Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,2.3
1379,8DFH,L,50,IGLV1-47,R,['R' 'S'],Crystal structure of non-neutralizing / interfering human monoclonal antibody 42C3 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,2.3
1380,8DFI,H,50,IGHV3-30,F,['V' 'F'],Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,1.9
1381,8DFI,H,52,IGHV3-30,R,['S' 'R'],Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,1.9
1382,8DFI,L,50,IGLV1-47,R,['R' 'S'],Crystal structure of moderately neutralizing / interfering human monoclonal antibody 42C11 Fab in complex with MSP1-19,merozoite surface protein 1,A,plasmodium falciparum 3d7,1.9
1383,8D36,H,50,IGHV1-2,R,['R' 'W'],Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62,spike protein s2 fusion peptide,F,severe acute respiratory syndrome coronavirus2 ,1.45
1384,6IVZ,H,26,IGHV4-59,G,['G' 'S'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1385,6IVZ,H,27,IGHV4-59,G,['G' 'I'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1386,6IVZ,H,29,IGHV4-59,T,['I' 'V' 'S'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1387,6IVZ,H,30,IGHV4-59,Y,['S' 'Y'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1388,6IVZ,H,31,IGHV4-59,N,['S' 'Y'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1389,6IVZ,H,32,IGHV4-59,H,['Y' 'W' 'H'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1390,6IVZ,H,53,IGHV4-59,Y,['Y' 'T'],Crystal structure of 5A ScFv complexed with YFV-China sE in postfusion state,envelope protein,A,yellow fever virus,2.4
1391,3LZF,H,33,IGHV2-70,G,['G' 'E'],Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin,"hemagglutinin, ha1 subunit",A,influenza a virus,2.8
1392,3LZF,H,35,IGHV2-70,S,['C' 'R'],Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin,"hemagglutinin, ha1 subunit",A,influenza a virus,2.8
1393,3LZF,H,50,IGHV2-70,L,['L' 'R'],Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin,"hemagglutinin, ha1 subunit",A,influenza a virus,2.8
1394,6XQW,H,50,IGHV4-34,E,['E' 'Y'],Crystal Structure of MaliM03 Fab in complex with Pfmsp1-19,pfmsp1-19,E,plasmodium falciparum,2.991
1395,6XQW,L,50,IGLV1-47,R,['R' 'S'],Crystal Structure of MaliM03 Fab in complex with Pfmsp1-19,pfmsp1-19,E,plasmodium falciparum,2.991
1396,3MAC,H,33,IGHV1-69,A,['A' 'T'],crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.5
1397,3MAC,H,50,IGHV1-69,S,['G' 'R'],crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.5
1398,3MAC,H,54,IGHV1-69,F,['F' 'L'],crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.5
1399,3MAC,H,56,IGHV1-69,F,['T' 'I'],crystal structure of GP41-derived protein complexed with fab 8062,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.5
1400,7A3U,L,50,IGLV2-14,D,['E' 'D'],Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus,3.0
1401,7A3U,L,51,IGLV2-14,V,['V' 'G'],Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus,3.0
1402,7A3U,L,53,IGLV2-14,S,['N' 'K'],Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus,3.0
1403,7A3U,L,60,IGLV2-14,S,['N' 'D'],Crystal structure of Zika virus envelope glycoprotein in complex with the divalent F(ab')2 fragment of the broadly neutralizing human antibody EDE1 C10,envelope protein,A,zika virus,3.0
1404,7A3N,L,50,IGLV2-14,D,['E' 'D'],Crystal structure of Zika virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,zika virus,2.1
1405,7A3N,L,53,IGLV2-14,S,['N' 'K'],Crystal structure of Zika virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,zika virus,2.1
1406,7A3N,L,60,IGLV2-14,S,['N' 'D'],Crystal structure of Zika virus envelope glycoprotein in complex with the Fab fragment of the broadly neutralizing human antibody EDE1 C10,core protein,A,zika virus,2.1
1407,4I3R,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus,3.0
1408,4I3R,H,61,IGHV1-2,P,['Q' 'H'],Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus,3.0
1409,4I3S,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P21,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus,2.85
1410,4I3S,H,61,IGHV1-2,P,['Q' 'H'],Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P21,outer domain of hiv-1 gp120 (ker2018 od4.2.2),G,human immunodeficiency virus,2.85
1411,4ERS,L,10,IGKV1-17,S,['S' 'A'],A Molecular Basis for Negative Regulation of the Glucagon Receptor,glucagon receptor,A,homo sapiens,2.637
1412,4ERS,L,11,IGKV1-17,L,['L' 'M'],A Molecular Basis for Negative Regulation of the Glucagon Receptor,glucagon receptor,A,homo sapiens,2.637
1413,7N4I,H,74,IGHV5-51,S,['S' 'P'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.,spike protein s1,C,severe acute respiratory syndrome coronavirus2 ,2.284
1414,7N4N,D,58,IGHV3-74,T,['S' 'T'],BACE-2 in complex with ligand 36,beta-secretase 2,A,homo sapiens,1.41
1415,7N4L,H,50,IGHV3-30,V,['V' 'F'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.601
1416,7N4L,H,52,IGHV3-30,S,['S' 'R'],Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.,spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.601
1417,4HKX,A,50,IGHV1-2,W,['R' 'W'],Influenza hemagglutinin in complex with CH67 Fab,hemagglutinin ha1,E,influenza a virus,2.5
1418,1G9M,H,54,IGHV1-69,L,['F' 'L'],HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.2
1419,1G9M,H,56,IGHV1-69,V,['T' 'I'],HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B,envelope glycoprotein gp120,G,human immunodeficiency virus 1,2.2
1420,3MA9,H,33,IGHV1-69,A,['A' 'T'],Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.05
1421,3MA9,H,50,IGHV1-69,S,['G' 'R'],Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.05
1422,3MA9,H,54,IGHV1-69,F,['F' 'L'],Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.05
1423,3MA9,H,56,IGHV1-69,T,['T' 'I'],Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.05
1424,3MA9,H,73,IGHV1-69,E,['E' 'K'],Crystal structure of gp41 derived protein complexed with fab 8066,transmembrane glycoprotein,A,human immunodeficiency virus 1,2.05
1425,6YXD,H,50,IGHV1-2,D,['R' 'W'],Room temperature structure of human adiponectin receptor 2 (ADIPOR2) at 2.9 A resolution determined by Serial Crystallography (SSX) using CrystalDirect,adiponectin receptor protein 2,A,homo sapiens,2.9
1426,5SY8,H,50,IGHV3-15,R,['R' 'C'],Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold,10e8 epitope scaffold t117v2,O,synthetic construct,1.62
1427,5SY8,H,52,IGHV3-15,T,['K' 'E'],Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold,10e8 epitope scaffold t117v2,O,synthetic construct,1.62
1428,5SY8,H,52C,IGHV3-15,G,['T' 'A'],Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold,10e8 epitope scaffold t117v2,O,synthetic construct,1.62
1429,5SY8,H,53,IGHV3-15,E,['D' 'N'],Crystal structure of the complex of 10E8 Fab light chain mutant1 and T117v2 HIV-1 MPER scaffold,10e8 epitope scaffold t117v2,O,synthetic construct,1.62
1430,7YE5,H,33,IGHV1-69,A,['A' 'T'],SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,6.75
1431,7YE5,H,54,IGHV1-69,L,['F' 'L'],SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,6.75
1432,7YE5,H,56,IGHV1-69,I,['T' 'I'],SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,6.75
1433,7YE5,H,73,IGHV1-69,K,['E' 'K'],SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,6.75
1434,7YE5,L,69,IGLV1-40,T,['T' 'A'],SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs,spike glycoprotein | spike glycoprotein,A | B,severe acute respiratory syndrome coronavirus2  | severe acute respiratory syndrome coronavirus2 ,6.75
1435,6AXK,A,31,IGHV3-33,N,['S' 'R'],Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum,2.103
1436,6AXK,A,35,IGHV3-33,H,['H' 'Y'],Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum,2.103
1437,6AXK,A,52,IGHV3-33,W,['W' 'S'],Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum,2.103
1438,6AXK,A,94,IGHV3-33,R,['R' 'K'],Crystal structure of Fab311 complex,ace-asn-pro-asn-ala-asn-pro-asn-ala-asn-pro-asn,E,plasmodium falciparum,2.103
1439,7SWP,H,26,IGHV3-30,G,['G' 'A'],G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.8
1440,7SWP,H,94,IGHV3-30,R,['R' 'K'],G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,3.8
1441,6Q0O,Z,31,IGHV4-4,S,['S' 'N'],human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus,3.0
1442,6Q0O,Z,32,IGHV4-4,S,['S' 'W' 'Y'],human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus,3.0
1443,6Q0O,Z,33,IGHV4-4,Q,['N' 'W' 'Y'],human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus,3.0
1444,6Q0O,Z,34,IGHV4-4,W,['W' 'S'],human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus,3.0
1445,6Q0O,Z,53,IGHV4-4,H,['H' 'T'],human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1),hemagglutinin head domain,A,influenza a virus,3.0
1446,7SWO,H,54,IGHV3-66,G,['G' 'C'],C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction),spike protein s1,A,severe acute respiratory syndrome coronavirus2 ,4.1
1447,6Q0I,H,31,IGHV4-4,S,['S' 'N'],Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.702
1448,6Q0I,H,32,IGHV4-4,S,['S' 'W' 'Y'],Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.702
1449,6Q0I,H,33,IGHV4-4,N,['N' 'W' 'Y'],Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.702
1450,6Q0I,H,34,IGHV4-4,W,['W' 'S'],Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.702
1451,6Q0I,H,53,IGHV4-4,H,['H' 'T'],Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.702
1452,6Q0H,H,31,IGHV4-4,S,['S' 'N'],Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.75
1453,6Q0H,H,32,IGHV4-4,S,['S' 'W' 'Y'],Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.75
1454,6Q0H,H,34,IGHV4-4,W,['W' 'S'],Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.75
1455,6Q0H,H,53,IGHV4-4,H,['H' 'T'],Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.75
1456,6Q0E,H,31,IGHV4-4,S,['S' 'N'],Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.15
1457,6Q0E,H,32,IGHV4-4,S,['S' 'W' 'Y'],Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.15
1458,6Q0E,H,53,IGHV4-4,H,['H' 'T'],Inferred precursor (UCA) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1),hemagglutinin,A,influenza a virus (a/beijing/262/1995(h1n1)),2.15
1459,7CWO,H,33,IGHV3-30,A,['A' 'G'],SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
1460,7CWO,H,50,IGHV3-30,V,['V' 'F'],SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
1461,7CWO,H,52,IGHV3-30,S,['S' 'R'],SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
1462,7CWO,H,94,IGHV3-30,R,['R' 'K'],SARS-CoV-2 spike protein RBD and P17 fab complex,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.9
1463,3R1G,H,50,IGHV3-23,W,['A' 'V'],Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody,beta-secretase 1,B,homo sapiens,2.8
1464,3R1G,H,52,IGHV3-23,S,['S' 'Y'],Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody,beta-secretase 1,B,homo sapiens,2.8
1465,3R1G,H,53,IGHV3-23,A,['S' 'G'],Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody,beta-secretase 1,B,homo sapiens,2.8
1466,8E7M,H,52,IGHV3-23,S,['S' 'Y'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1467,8E7M,H,52A,IGHV3-23,G,['G' 'S'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1468,8E7M,H,53,IGHV3-23,S,['S' 'G'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1469,8E7M,H,55,IGHV3-23,D,['G' 'S'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1470,8E7M,L,30,IGKV1-17,S,['R' 'S'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1471,8E7M,L,32,IGKV1-17,Y,['D' 'Y'],"Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04",angiotensin-converting enzyme 2,A,homo sapiens,0
1472,7SOA,H,26,IGHV3-30,G,['G' 'A'],SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.1
1473,7SOA,H,52,IGHV3-30,R,['S' 'R'],SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.1
1474,3D0V,B,54,IGHV2-5,D,['N' 'D'],Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LLELDKWASLW,gp41 peptide lleldkwaslw,C,,2.05
1475,5M2J,D,58,IGHV3-74,K,['S' 'T'],Complex between human TNF alpha and Llama VHH2,tumor necrosis factor,A,homo sapiens,1.9
1476,6YX9,H,50,IGHV1-2,D,['R' 'W'],Cryogenic human adiponectin receptor 2 (ADIPOR2) at 2.4 A resolution determined by Serial Crystallography (SSX) using CrystalDirect,adiponectin receptor protein 2,A,homo sapiens,2.404
1477,7LJR,S,50,IGHV1-69,R,['G' 'R'],SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.66
1478,7LJR,S,54,IGHV1-69,F,['F' 'L'],SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.66
1479,7LJR,S,56,IGHV1-69,I,['T' 'I'],SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab,spike glycoprotein,A,severe acute respiratory syndrome coronavirus2 ,3.66
1480,6YXK,A,50,IGHV1-2,W,['R' 'W'],Crystal structure of ACPA 3F3 in complex with cit-vimentin 59-74,citrullinated vimentin (59-74),C,homo sapiens,2.0
1481,5T29,H,50,IGHV3-15,R,['R' 'C'],"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct,2.03
1482,5T29,H,52,IGHV3-15,T,['K' 'E'],"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct,2.03
1483,5T29,H,52C,IGHV3-15,G,['T' 'A'],"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct,2.03
1484,5T29,H,53,IGHV3-15,E,['D' 'N'],"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct,2.03
1485,5T29,H,58,IGHV3-15,D,['D' 'N'],"Crystal structure of 10E8 Fab light chain mutant3, against the MPER region of the HIV-1 Env, in complex with the MPER epitope scaffold T117v2",10e8 epitope scaffold t117v2,O,synthetic construct,2.03
1486,4XMP,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1,1.7831
1487,4XMP,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC08 in complex with HIV-1 clade A strain Q842.d12 gp120,"envelope glycoprotein gp160,envelope glycoprotein gp160,envelope glycoprotein gp160 ",G,human immunodeficiency virus 1,1.7831
1488,7NCS,H,50,IGHV3-21,Y,['S' 'Y'],"Lateral-open conformation of the lid-locked BAM complex (BamA E435C S665C, BamBDCE) bound by a bactericidal Fab fragment",outer membrane protein assembly factor bama,A,escherichia coli k-12,7.1
1489,5TZU,H,50,IGHV3-21,T,['S' 'Y'],Crystal structure of human CD47 ECD bound to Fab of B6H12.2,leukocyte surface antigen cd47,C,homo sapiens,2.1
1490,3NPS,B,54,IGHV1-69,F,['F' 'L'],Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4,suppressor of tumorigenicity 14 protein,A,homo sapiens,1.5
1491,3NPS,C,50,IGLV1-47,D,['R' 'S'],Crystal structure of membrane-type serine protease 1 (MT-SP1) in complex with the Fab Inhibitor S4,suppressor of tumorigenicity 14 protein,A,homo sapiens,1.5
1492,5IQ7,H,50,IGHV3-15,R,['R' 'C'],Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.,gp41 mper peptide,P,human immunodeficiency virus 1,3.2869
1493,5IQ7,H,52,IGHV3-15,T,['K' 'E'],Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.,gp41 mper peptide,P,human immunodeficiency virus 1,3.2869
1494,5IQ7,H,52C,IGHV3-15,G,['T' 'A'],Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.,gp41 mper peptide,P,human immunodeficiency virus 1,3.2869
1495,5IQ7,H,53,IGHV3-15,E,['D' 'N'],Crystal structure of 10E8-S74W Fab in complex with an HIV-1 gp41 peptide.,gp41 mper peptide,P,human immunodeficiency virus 1,3.2869
1496,5OCK,L,50,IGLV1-51,D,['D' 'E'],Crystal structure of ACPA E4 in complex with CEP1,cep1 peptide (from enolase),A,homo sapiens,1.6
1497,7WTG,H,33,IGHV1-69,A,['A' 'T'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1498,7WTG,H,50,IGHV1-69,G,['G' 'R'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1499,7WTG,H,54,IGHV1-69,F,['F' 'L'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1500,7WTG,H,56,IGHV1-69,T,['T' 'I'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1501,7WTG,L,30,IGKV1-17,R,['R' 'S'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1502,7WTG,L,32,IGKV1-17,D,['D' 'Y'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1503,7WTH,H,54,IGHV2-5,D,['N' 'D'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1504,7WTH,L,29,IGLV2-14,N,['G' 'S'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1505,7WTH,L,32,IGLV2-14,Y,['Y' 'L'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1506,7WTH,L,50,IGLV2-14,E,['E' 'D'],SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264,spike protein s1,E,severe acute respiratory syndrome coronavirus2 ,0
1507,6H2Y,H,33,IGHV1-69,P,['A' 'T'],human Fab 1E6 bound to fHbp variant 3 from Neisseria meningitidis serogroup B,lipoprotein gna1870,D,neisseria meningitidis,2.65
1508,6H2Y,H,54,IGHV1-69,F,['F' 'L'],human Fab 1E6 bound to fHbp variant 3 from Neisseria meningitidis serogroup B,lipoprotein gna1870,D,neisseria meningitidis,2.65
1509,6H2Y,L,50,IGLV3-21,Y,['Y' 'D'],human Fab 1E6 bound to fHbp variant 3 from Neisseria meningitidis serogroup B,lipoprotein gna1870,D,neisseria meningitidis,2.65
1510,3SO3,C,50,IGHV3-23,A,['A' 'V'],Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens,2.1
1511,3SO3,C,52,IGHV3-23,S,['S' 'Y'],Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens,2.1
1512,3SO3,C,52A,IGHV3-23,G,['G' 'S'],Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens,2.1
1513,3SO3,C,53,IGHV3-23,S,['S' 'G'],Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens,2.1
1514,3SO3,C,55,IGHV3-23,G,['G' 'S'],Structures of Fab-Protease Complexes Reveal a Highly Specific Non-Canonical Mechanism of Inhibition.,suppressor of tumorigenicity 14 protein,A,homo sapiens,2.1
1515,3SE8,H,50,IGHV1-2,W,['R' 'W'],Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1,1.895
1516,3SE8,H,61,IGHV1-2,R,['Q' 'H'],Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120,hiv-1 clade ae strain 93th057 gp120,G,human immunodeficiency virus 1,1.895
